Prescription ID | TCMF5458 |
Pinyin Name | Qing Ning Wan |
Chinese Name | 清宁丸 |
English Name | Qing Ning Pills |
Function Description | 喉痹, 口疮, 眩晕, 耳鸣, 牙痛, 腹胀, 便秘 |
Indications | Constipation disorder, Tinnitus disorder, Vertigo disorder, Constipation, Tinnitus, Pharyngitis, Aphtha, Dizziness |
Disease ICD-11 Category |
SA57 [Constipation disorder (TM1), 便秘 (TM1)
]; SC75 [Tinnitus disorder (TM1), 耳鸣 (TM1) ]; SD22 [Vertigo disorder (TM1), 眩晕 (TM1) ]; ME05.0 [Constipation, 便秘 ]; MC41 [Tinnitus, 耳鸣 ]; CA0Z [Upper respiratory tract disorders, unspecified, 上呼吸道疾患,未特指的 ]; DA01.10 [Oral aphthae or aphtha-like ulceration, 口腔阿弗他溃疡或阿弗他样溃疡 ]; MB48 [Dizziness and giddiness, 头晕和眩晕 ]; |
Human Tissues Associated with Indication | Lung, Liver, Spleen, Brain, Stomach, Large Intestine |
Reference | CFDA |
Reference Book/link | http://samr.cfda.gov.cn/WS01/CL0001/ |
Component ID | Latin Name | Chinese Name | Component Quantity | Barcode |
---|---|---|---|---|
TCMH363 | Rheum officinale | 大黄 | TCMH363 | ITSAJ4685-14 |
TCMH1383 | Onobrychis viciifolia | 绿豆 | TCMH1383 | ITSAJ2861-14 |
TCMH240 | Plantago depressa | 车前草 | TCMH240 | ITSAM917-14 |
TCMH120 | Atractylodes macrocephala | 白术 | TCMH120 | ITSAN4430-14 |
TCMH834 | Semen glycine max | 黑豆 | TCMH834 | ITSAJ4675-14 |
TCMH130 | Pinellia ternata | 半夏 | TCMH130 | GBVT1123-13, GBVY1693-14 |
TCMH2265 | Cyperus rotundus | 香附 | TCMH2265 | GENG1049-15 |
TCMH1797 | Morus alba | 桑叶 | TCMH1797 | ITSAL1073-14 |
TCMH2077 | Prunus persica | 桃枝 | TCMH2077 | ITSAN1047-14 |
TCMH1580 | Bos taurus domesticus | 牛乳 | TCMH1580 | |
TCMH890 | Cortex magnoliae officinalis | 厚朴 | TCMH890 | ITSAM1591-14 |
TCMH1430 | Hordeum vulgare | 麦芽 | TCMH1430 | ITSAI3101-14 |
TCMH243 | Pericarpium citri reticulatae | 陈皮 | TCMH243 | |
TCMH224 | Thuja orientalis | 侧柏叶 | TCMH224 | ITSAJ4756-14 |
Target ID | Gene Symbol | Target Name | Target Class | Uniprot ID |
---|---|---|---|---|
TCMT100 | TTR | Transthyretin | Unclassified | P02766 |
TCMT101 | PTPN1 | Protein-tyrosine phosphatase 1B | Hydrolase | P18031 |
TCMT11 | HIF1A | Hypoxia-inducible factor 1 alpha | Transcription factor | Q16665 |
TCMT112 | ADORA3 | Adenosine A3 receptor | GPCR | P0DMS8 |
TCMT114 | CNR2 | Cannabinoid CB2 receptor | GPCR | P34972 |
TCMT115 | CNR1 | Cannabinoid CB1 receptor | GPCR | P21554 |
TCMT118 | MGAM | Maltase-glucoamylase | Hydrolase | O43451 |
TCMT124 | FUCA1 | Alpha-L-fucosidase I | Hydrolase | P04066 |
TCMT125 | GBA | Beta-glucocerebrosidase | Hydrolase | P04062 |
TCMT126 | TERT | Telomerase reverse transcriptase | Transferase | O14746 |
TCMT127 | PARP1 | Poly [ADP-ribose] polymerase-1 | Transferase | P09874 |
TCMT13 | APEX1 | DNA-(apurinic or apyrimidinic site) lyase | Lyase | P27695 |
TCMT130 | ALOX5 | Arachidonate 5-lipoxygenase | Oxidoreductase | P09917 |
TCMT131 | ACHE | Acetylcholinesterase | Hydrolase | P22303 |
TCMT133 | CA1 | Carbonic anhydrase I | Lyase | P00915 |
TCMT134 | CA2 | Carbonic anhydrase II | Lyase | P00918 |
TCMT135 | CA14 | Carbonic anhydrase XIV | Lyase | Q9ULX7 |
TCMT136 | CA12 | Carbonic anhydrase XII | Lyase | O43570 |
TCMT137 | CA9 | Carbonic anhydrase IX | Lyase | Q16790 |
TCMT138 | CA7 | Carbonic anhydrase VII | Lyase | P43166 |
TCMT142 | CA4 | Carbonic anhydrase IV | Lyase | P22748 |
TCMT156 | CYP19A1 | Cytochrome P450 19A1 | Oxidoreductase | P11511 |
TCMT159 | TYR | Tyrosinase | Oxidoreductase | P14679 |
TCMT160 | HTR7 | Serotonin 7 (5-HT7) receptor | GPCR | P34969 |
TCMT161 | HCAR2 | Hydroxycarboxylic acid receptor 2 | GPCR | Q8TDS4 |
TCMT162 | UGT1A1 | UDP-glucuronosyltransferase 1-1 | Transferase | P22309 |
TCMT164 | PTGS1 | Cyclooxygenase-1 | Oxidoreductase | P23219 |
TCMT174 | HSD11B1 | 11-beta-hydroxysteroid dehydrogenase 1 | Oxidoreductase | P28845 |
TCMT18 | GAA | Lysosomal alpha-glucosidase | Hydrolase | P10253 |
TCMT189 | DUSP3 | Dual specificity protein phosphatase 3 | Hydrolase | P51452 |
TCMT190 | PTPN2 | T-cell protein-tyrosine phosphatase | Hydrolase | P17706 |
TCMT197 | PDE4D | Phosphodiesterase 4D | Hydrolase | Q08499 |
TCMT2 | MAPT | Microtubule-associated protein tau | Unclassified | P10636 |
TCMT207 | BACE1 | Beta-secretase 1 | Protease | P56817 |
TCMT209 | HSD11B2 | 11-beta-hydroxysteroid dehydrogenase 2 | Oxidoreductase | P80365 |
TCMT212 | SRC | Tyrosine-protein kinase SRC | Kinase | P12931 |
TCMT215 | CYP1A1 | Cytochrome P450 1A1 | Oxidoreductase | P04798 |
TCMT217 | CYP2C8 | Cytochrome P450 2C8 | Oxidoreductase | P10632 |
TCMT219 | CYP1A2 | Cytochrome P450 1A2 | Oxidoreductase | P05177 |
TCMT223 | AKR1B1 | Aldose reductase | Oxidoreductase | P15121 |
TCMT23 | ALPL | Alkaline phosphatase, tissue-nonspecific isozyme | Hydrolase | P05186 |
TCMT232 | ABCB1 | P-glycoprotein 1 | Transporter | P08183 |
TCMT239 | PIM1 | Serine/threonine-protein kinase PIM1 | Kinase | P11309 |
TCMT242 | HRH3 | Histamine H3 receptor | GPCR | Q9Y5N1 |
TCMT245 | HRH2 | Histamine H2 receptor | GPCR | P25021 |
TCMT246 | HRH4 | Histamine H4 receptor | GPCR | Q9H3N8 |
TCMT254 | CBR1 | Carbonyl reductase [NADPH] 1 | Oxidoreductase | P16152 |
TCMT257 | CYP1B1 | Cytochrome P450 1B1 | Oxidoreductase | Q16678 |
TCMT260 | FLT3 | Tyrosine-protein kinase receptor FLT3 | Kinase | P36888 |
TCMT261 | DAPK1 | Death-associated protein kinase 1 | Kinase | P53355 |
TCMT280 | AKR1B10 | Aldo-keto reductase family 1 member B10 | Oxidoreductase | O60218 |
TCMT295 | MMP1 | Matrix metalloproteinase-1 | Hydrolase | P03956 |
TCMT296 | ADORA1 | Adenosine A1 receptor | GPCR | P30542 |
TCMT297 | FABP4 | Fatty acid binding protein adipocyte | Unclassified | P15090 |
TCMT298 | FABP3 | Fatty acid binding protein muscle | Hydrolase | P05413 |
TCMT3 | ALOX15 | Arachidonate 15-lipoxygenase | Oxidoreductase | P16050 |
TCMT30 | PTGS2 | Cyclooxygenase-2 | Oxidoreductase | P35354 |
TCMT304 | MMP14 | Matrix metalloproteinase 14 | Hydrolase | P50281 |
TCMT306 | MMP2 | Matrix metalloproteinase-2 | Hydrolase | P08253 |
TCMT313 | HTR2B | Serotonin 2b (5-HT2b) receptor | GPCR | P41595 |
TCMT314 | HTR2C | Serotonin 2c (5-HT2c) receptor | GPCR | P28335 |
TCMT315 | HTR6 | Serotonin 6 (5-HT6) receptor | GPCR | P50406 |
TCMT318 | HKDC1 | Putative hexokinase HKDC1 | Transferase | Q2TB90 |
TCMT321 | MMP9 | Matrix metalloproteinase 9 | Hydrolase | P14780 |
TCMT322 | MMP13 | Matrix metalloproteinase 13 | Hydrolase | P45452 |
TCMT329 | NQO2 | Quinone reductase 2 | Oxidoreductase | P16083 |
TCMT335 | MPO | Myeloperoxidase | Oxidoreductase | P05164 |
TCMT336 | IDO1 | Indoleamine 2,3-dioxygenase | Oxidoreductase | P14902 |
TCMT347 | MAN1B1 | Endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidase | Hydrolase | Q9UKM7 |
TCMT354 | AURKA | Serine/threonine-protein kinase Aurora-A | Kinase | O14965 |
TCMT36 | HTR1A | Serotonin 1a (5-HT1a) receptor | GPCR | P08908 |
TCMT369 | IGF1R | Insulin-like growth factor I receptor | Kinase | P08069 |
TCMT37 | HTR2A | Serotonin 2a (5-HT2a) receptor | GPCR | P28223 |
TCMT370 | KDR | Vascular endothelial growth factor receptor 2 | Kinase | P35968 |
TCMT374 | AURKB | Serine/threonine-protein kinase Aurora-B | Kinase | Q96GD4 |
TCMT377 | INSR | Insulin receptor | Kinase | P06213 |
TCMT384 | GRK6 | G protein-coupled receptor kinase 6 | Kinase | P43250 |
TCMT388 | AXL | Tyrosine-protein kinase receptor UFO | Kinase | P30530 |
TCMT401 | MET | Hepatocyte growth factor receptor | Kinase | P08581 |
TCMT418 | EPHB4 | Ephrin type-B receptor 4 | Kinase | P54760 |
TCMT422 | CAMK2B | CaM kinase II beta | Kinase | Q13554 |
TCMT423 | EGFR | Epidermal growth factor receptor erbB1 | Kinase | P00533 |
TCMT436 | NUAK1 | NUAK family SNF1-like kinase 1 | Kinase | O60285 |
TCMT44 | GLO1 | Glyoxalase I | Lyase | Q04760 |
TCMT445 | NEK2 | Serine/threonine-protein kinase NEK2 | Kinase | P51955 |
TCMT45 | APP | Beta amyloid A4 protein | Unclassified | P05067 |
TCMT457 | FLT4 | Vascular endothelial growth factor receptor 3 | Kinase | P35916 |
TCMT462 | NEK6 | Serine/threonine-protein kinase NEK6 | Kinase | Q9HC98 |
TCMT47 | BCL2 | Apoptosis regulator Bcl-2 | Ion channel | P10415 |
TCMT479 | AKT1 | Serine/threonine-protein kinase AKT | Kinase | P31749 |
TCMT484 | PLK1 | Serine/threonine-protein kinase PLK1 | Kinase | P53350 |
TCMT502 | TEK | Tyrosine-protein kinase TIE-2 | Kinase | Q02763 |
TCMT508 | SYK | Tyrosine-protein kinase SYK | Kinase | P43405 |
TCMT536 | PDGFRB | Platelet-derived growth factor receptor beta | Kinase | P09619 |
TCMT558 | TOP2A | DNA topoisomerase II alpha | Isomerase | P11388 |
TCMT563 | CDC25B | Dual specificity phosphatase Cdc25B | Hydrolase | P30305 |
TCMT567 | DNMT1 | DNA (cytosine-5)-methyltransferase 1 | Transferase | P26358 |
TCMT571 | ADORA2B | Adenosine A2b receptor | GPCR | P29275 |
TCMT588 | DAO | D-amino-acid oxidase | Oxidoreductase | P14920 |
TCMT592 | XDH | Xanthine dehydrogenase | Oxidoreductase | P47989 |
TCMT597 | SLC28A3 | Solute carrier family 28 member 3 | Transporter | Q9HAS3 |
TCMT599 | UBE2N | Ubiquitin-conjugating enzyme E2 N | Transferase | P61088 |
TCMT626 | BRAF | Serine/threonine-protein kinase B-raf | Kinase | P15056 |
TCMT63 | PPARA | Peroxisome proliferator-activated receptor alpha | Nuclear receptor | Q07869 |
TCMT637 | SIRT3 | NAD-dependent deacetylase sirtuin 3 | Hydrolase | Q9NTG7 |
TCMT638 | SIRT2 | NAD-dependent deacetylase sirtuin 2 | Hydrolase | Q8IXJ6 |
TCMT645 | HTR1E | Serotonin 1e (5-HT1e) receptor | GPCR | P28566 |
TCMT646 | HTR5A | Serotonin 5a (5-HT5a) receptor | GPCR | P47898 |
TCMT65 | HSD17B1 | Estradiol 17-beta-dehydrogenase 1 | Oxidoreductase | P14061 |
TCMT66 | HSD17B2 | Estradiol 17-beta-dehydrogenase 2 | Oxidoreductase | P37059 |
TCMT666 | VCP | Transitional endoplasmic reticulum ATPase | Transporter | P55072 |
TCMT698 | PDE4B | Phosphodiesterase 4B | Hydrolase | Q07343 |
TCMT709 | SLC28A2 | Sodium/nucleoside cotransporter 2 | Transporter | O43868 |
TCMT710 | SLC28A1 | Sodium/nucleoside cotransporter 1 | Transporter | O00337 |
TCMT721 | HSPA1A | Heat shock 70 kDa protein 1 | Unclassified | P0DMV8 |
TCMT729 | PIK3CA | PI3-kinase p110-alpha subunit | Transferase | P42336 |
TCMT730 | PIK3CB | PI3-kinase p110-beta subunit | Transferase | P42338 |
TCMT734 | MMP12 | Matrix metalloproteinase 12 | Hydrolase | P39900 |
TCMT737 | APOBEC3G | DNA dC->dU-editing enzyme APOBEC-3G | Unclassified | Q9HC16 |
TCMT739 | GPR35 | G-protein coupled receptor 35 | GPCR | Q9HC97 |
TCMT740 | PIK3CG | PI3-kinase p110-gamma subunit | Transferase | P48736 |
TCMT751 | DYRK1A | Dual-specificity tyrosine-phosphorylation regulated kinase 1A | Kinase | Q13627 |
TCMT752 | CSNK2A1 | Casein kinase II alpha | Kinase | P68400 |
TCMT753 | SMAD3 | Mothers against decapentaplegic homolog 3 | Unclassified | P84022 |
TCMT755 | PLK4 | Serine/threonine-protein kinase PLK4 | Kinase | O00444 |
TCMT756 | MAP3K8 | Mitogen-activated protein kinase kinase kinase 8 | Kinase | P41279 |
TCMT784 | AVPR2 | Vasopressin V2 receptor | GPCR | P30518 |
TCMT785 | CXCR1 | Interleukin-8 receptor A | GPCR | P25024 |
TCMT786 | CCR4 | C-C chemokine receptor type 4 | GPCR | P51679 |
TCMT791 | PKN1 | Protein kinase N1 | Kinase | Q16512 |
TCMT793 | PYGL | Liver glycogen phosphorylase | Transferase | P06737 |
TCMT8 | KDM4E | Lysine-specific demethylase 4D-like | Oxidoreductase | B2RXH2 |
TCMT807 | SLC22A12 | Solute carrier family 22 member 12 | Transporter | Q96S37 |
TCMT808 | FABP5 | Fatty acid binding protein epidermal | Unclassified | Q01469 |
TCMT809 | FABP2 | Fatty acid binding protein intestinal | Unclassified | P12104 |
TCMT810 | TLR2 | Toll-like receptor 2 | Unclassified | O60603 |
TCMT815 | HTR1D | Serotonin 1d (5-HT1d) receptor | GPCR | P28221 |
TCMT816 | HTR1B | Serotonin 1b (5-HT1b) receptor | GPCR | P28222 |
TCMT817 | HTR4 | Serotonin 4 (5-HT4) receptor | GPCR | Q13639 |
TCMT82 | ESR1 | Estrogen receptor alpha | Nuclear receptor | P03372 |
TCMT822 | FUT7 | Alpha-(1,3)-fucosyltransferase 7 | Transferase | Q11130 |
TCMT83 | CD38 | Lymphocyte differentiation antigen CD38 | Unclassified | P28907 |
TCMT87 | CYP2C9 | Cytochrome P450 2C9 | Oxidoreductase | P11712 |
Target ID | Target Name |
---|---|
TCMT1170 | Enterobacter cloacae |
TCMT1172 | Staphylococcus aureus subsp. aureus RN4220 |
TCMT1175 | Human immunodeficiency virus |
TCMT1176 | Streptococcus pneumoniae |
TCMT1178 | Actinomyces viscosus |
TCMT1179 | Escherichia coli ATCC 8739 |
TCMT1181 | Mycobacterium tuberculosis H37Ra |
TCMT1182 | Streptococcus sanguinis |
TCMT1183 | Candida albicans SC5314 |
TCMT1189 | Pseudomonas fluorescens |
TCMT1190 | Plasmodium falciparum (isolate FcB1 / Columbia) |
TCMT1201 | Staphylococcus epidermidis ATCC 12228 |
TCMT1208 | Escherichia coli K12 |
TCMT1209 | Staphylococcus haemolyticus |
TCMT1210 | Streptococcus sobrinus |
TCMT1211 | Fusobacterium nucleatum |
TCMT1212 | Verticillium dahliae |
TCMT1213 | Neisseria gonorrhoeae |
TCMT1215 | Pseudomonas aeruginosa PAO1 |
TCMT1218 | Staphylococcus aureus |
TCMT1219 | Enterococcus |
TCMT1221 | Human herpesvirus 4 |
TCMT1222 | Plasmodium falciparum D6 |
TCMT1223 | Staphylococcus epidermidis |
TCMT1226 | Klebsiella pneumoniae |
TCMT1229 | Enterococcus faecalis |
TCMT1231 | Human herpesvirus 1 strain KOS |
TCMT1232 | Pseudomonas aeruginosa |
TCMT1243 | Aspergillus flavus |
TCMT1245 | Phytophthora cactorum |
TCMT1246 | Escherichia coli |
TCMT1248 | Hepatitis C virus |
TCMT1249 | Dengue virus 2 |
TCMT1251 | Candida albicans |
TCMT1253 | Penicillium chrysogenum |
TCMT1255 | Human immunodeficiency virus 1 |
TCMT1286 | Bacillus cereus |
TCMT1289 | Shigella dysenteriae |
TCMT1294 | Human parainfluenza virus 3 |
TCMT1318 | Human T-lymphotropic virus 1 |
TCMT1321 | Staphylococcus hominis |
TCMT1343 | Staphylococcus simulans |
TCMT1344 | Staphylococcus sciuri |
TCMT1346 | Helicobacter pylori |
TCMT1349 | Helicobacter pylori SS1 |
TCMT1353 | Plasmodium yoelii |
TCMT1361 | Neisseria meningitidis |
TCMT1370 | Prevotella melaninogenica |
TCMT1382 | Plasmodium falciparum (isolate K1 / Thailand) |
TCMT1408 | Colletotrichum gloeosporioides |
TCMT1412 | Salmonella typhimurium |
TCMT1438 | Plasmodium falciparum |
TCMT1439 | Mycobacterium smegmatis |
TCMT1442 | Leishmania donovani |
TCMT1443 | Leishmania amazonensis |
TCMT1444 | Fusarium oxysporum |
TCMT1447 | Respiratory syncytial virus |
TCMT1448 | Enterobacter aerogenes |
TCMT1449 | Influenza A virus |
TCMT1450 | Plasmodium falciparum 3D7 |
TCMT1454 | Bacillus subtilis |
TCMT1455 | Mycobacterium tuberculosis H37Rv |
TCMT1458 | Filobasidiella neoformans |
TCMT1462 | Streptococcus mutans |
TCMT1463 | Mycobacterium tuberculosis |
TCMT1464 | Hepatitis B virus |
TCMT1465 | Entamoeba histolytica |
GO Term | GO Name | Enriched Genes | Log10 Adjusted P-value |
---|---|---|---|
[BP] GO:0065008 | regulation of biological quality | ABCB1, ACHE, ADORA1, AKR1B1, ALOX15, APEX1, APP, AURKB, AXL, BCL2, CA12, CA2, CA7, CNR1, CNR2, CYP19A1, CYP1A1, CYP1B1, EGFR, ESR1, FABP3, FABP4, FLT3, GAA, GBA, GPR35, HCAR2, HIF1A, HRH3, HRH4, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR4, HTR7, INSR, KDR, MET, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2, SMAD3, SRC, TEK, TERT, XDH | 15.8578 |
[BP] GO:0007210 | None | HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 | 15.8578 |
[BP] GO:0098664 | None | HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 | 15.8578 |
[BP] GO:0042221 | response to chemical | ABCB1, AKR1B1, ALOX15, ALPL, APEX1, APP, AXL, BCL2, CA2, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, EGFR, ESR1, FABP3, FABP4, FLT3, GBA, HIF1A, HSD11B2, HSD17B2, HSPA1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR5A, IDO1, IGF1R, INSR, KDR, MMP2, MMP9, MPO, PIK3CA, PPARA, PTGS2, SMAD3, SRC, TEK, TERT, TYR | 15.2377 |
[BP] GO:1901700 | response to oxygen-containing compound | AKR1B1, ALPL, APEX1, APP, AXL, BCL2, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, EGFR, ESR1, FABP3, GBA, HSD11B2, HSD17B2, HTR1B, HTR5A, IDO1, IGF1R, INSR, MMP2, MMP9, MPO, PIK3CA, PPARA, PTGS2, SRC, TEK, TYR | 13.1274 |
[BP] GO:0010033 | response to organic substance | AKR1B1, ALOX15, ALPL, APEX1, APP, AXL, BCL2, CA2, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, EGFR, ESR1, FABP3, FABP4, FLT3, GBA, HIF1A, HSD11B2, HSD17B2, HSPA1A, HTR1B, HTR5A, IDO1, IGF1R, INSR, KDR, MMP2, MPO, PIK3CA, PPARA, PTGS2, SMAD3, SRC, TEK, TYR | 13.0088 |
[BP] GO:0010941 | regulation of cell death | ADORA1, AKR1B1, APEX1, AURKB, AXL, BCL2, CNR1, CSNK2A1, CYP1B1, EGFR, ESR1, FLT3, GBA, GLO1, HCAR2, HIF1A, HSPA1A, HTR2B, IDO1, IGF1R, KDR, MET, MMP9, MPO, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, TOP2A, XDH | 11.6993 |
[BP] GO:0010647 | positive regulation of cell communication | ADORA1, AKR1B1, ALOX15, APP, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, EGFR, FLT3, GBA, GPR35, HCAR2, HIF1A, HSPA1A, HTR2A, HTR2B, HTR2C, HTR6, INSR, KDR, MET, MMP12, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, XDH | 11.6715 |
[BP] GO:0023056 | positive regulation of signaling | ADORA1, AKR1B1, ALOX15, APP, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, EGFR, FLT3, GBA, GPR35, HCAR2, HIF1A, HSPA1A, HTR2A, HTR2B, HTR2C, HTR6, INSR, KDR, MET, MMP12, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, XDH | 11.6421 |
[BP] GO:0044281 | small molecule metabolic process | AKR1B1, AKR1B10, ALOX15, ALOX5, APP, CA1, CA12, CA2, CA4, CA7, CA9, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DAO, FABP3, FUCA1, FUT7, GAA, GBA, GLO1, HIF1A, HSPA1A, HTR2B, HTR2C, IDO1, MPO, PIK3CA, PIM1, PPARA, PTGS1, PTGS2, TYR, XDH | 11.2207 |
[BP] GO:0043067 | regulation of programmed cell death | ADORA1, AKR1B1, APEX1, AURKB, AXL, BCL2, CNR1, CSNK2A1, CYP1B1, EGFR, ESR1, FLT3, GLO1, HCAR2, HIF1A, HSPA1A, HTR2B, IDO1, IGF1R, KDR, MET, MMP9, MPO, PIK3CA, PIK3CB, PIM1, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, TOP2A, XDH | 11.1583 |
[BP] GO:0042127 | regulation of cell proliferation | ADORA1, ADORA3, AKR1B1, APP, BCL2, CDC25B, CSNK2A1, CYP1B1, DNMT1, EGFR, ESR1, FABP3, FLT3, HIF1A, HSPA1A, HTR1A, HTR1B, HTR2A, HTR2B, IDO1, IGF1R, INSR, KDR, MMP12, MMP2, MMP9, NUAK1, PIM1, PTGS1, PTGS2, SMAD3, SRC, TEK, TERT, XDH | 11.0795 |
[BP] GO:0010646 | regulation of cell communication | ACHE, ADORA1, AKR1B1, ALOX15, APP, AURKB, AXL, BACE1, BCL2, CA2, CA7, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DUSP3, DYRK1A, EGFR, ESR1, FLT3, GBA, GPR35, HCAR2, HIF1A, HRH4, HSPA1A, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, INSR, KDR, MET, MMP12, MMP9, NUAK1, PIK3CA, PIK3CB, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, XDH | 10.9019 |
[BP] GO:0023051 | regulation of signaling | ACHE, ADORA1, AKR1B1, ALOX15, APP, AURKB, AXL, BACE1, BCL2, CA2, CA7, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DUSP3, DYRK1A, EGFR, ESR1, FLT3, GBA, GPR35, HCAR2, HIF1A, HRH4, HSPA1A, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, INSR, KDR, MET, MMP12, MMP9, NUAK1, PIK3CA, PIK3CB, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, XDH | 10.7108 |
[BP] GO:0006629 | lipid metabolic process | ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, APP, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, FABP3, FABP4, FUCA1, FUT7, GBA, HSD11B1, HSD11B2, HSD17B1, HSD17B2, MET, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2 | 10.6103 |
[BP] GO:1902531 | regulation of intracellular signal transduction | ADORA1, AKR1B1, ALOX15, APP, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DUSP3, DYRK1A, EGFR, ESR1, FLT3, GBA, GPR35, HIF1A, HRH4, HSPA1A, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, INSR, KDR, MET, MMP9, NUAK1, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, TEK, XDH | 10.5945 |
[BP] GO:0032501 | multicellular organismal process | ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, APP, AXL, BCL2, CNR1, CNR2, CYP19A1, CYP1A2, CYP1B1, DUSP3, EGFR, ESR1, FABP4, GAA, GBA, HIF1A, HRH3, HSD11B2, HSD17B2, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR7, IDO1, IGF1R, INSR, MET, MGAM, MMP1, MMP12, MMP2, MMP9, MPO, PIK3CA, PIM1, PPARA, PTGS2, SMAD3, SRC, TEK, TYR | 10.5945 |
[BP] GO:0060548 | negative regulation of cell death | ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, EGFR, GBA, GLO1, HIF1A, HSPA1A, HTR2B, IDO1, IGF1R, KDR, MET, MMP9, MPO, PIK3CA, PIM1, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT | 10.5945 |
[BP] GO:0042981 | regulation of apoptotic process | ADORA1, AKR1B1, APEX1, AURKB, AXL, BCL2, CNR1, CSNK2A1, CYP1B1, EGFR, ESR1, FLT3, GLO1, HCAR2, HIF1A, HSPA1A, HTR2B, IDO1, IGF1R, KDR, MMP9, MPO, PIK3CA, PIK3CB, PIM1, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, TOP2A, XDH | 10.5945 |
[BP] GO:0033993 | response to lipid | ALPL, AXL, BCL2, CA2, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, EGFR, ESR1, FABP3, FLT3, GBA, HSD11B2, HSD17B2, HTR1B, HTR5A, IDO1, MPO, PTGS2, SRC, TYR | 10.5649 |
[BP] GO:0050896 | response to stimulus | ABCB1, ACHE, ADORA1, ADORA3, AKR1B1, ALOX15, ALPL, APEX1, APP, AURKB, AXL, BCL2, CA2, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, EGFR, ESR1, FABP3, FABP4, FLT3, GBA, HIF1A, HRH4, HSD11B2, HSD17B2, HSPA1A, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR5A, IDO1, IGF1R, INSR, KDR, MMP12, MMP2, MMP9, MPO, NUAK1, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, TOP2A, TYR | 9.83368 |
[BP] GO:0043069 | negative regulation of programmed cell death | ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, EGFR, GLO1, HIF1A, HSPA1A, HTR2B, IDO1, IGF1R, KDR, MET, MMP9, MPO, PIK3CA, PIM1, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT | 9.75222 |
[BP] GO:0009719 | response to endogenous stimulus | AKR1B1, ALPL, APEX1, APP, BCL2, CA2, CA9, CSNK2A1, CYP1A2, DNMT1, EGFR, ESR1, FABP3, FLT3, GBA, HSD11B2, HTR1B, HTR5A, IGF1R, INSR, MMP2, PPARA, PTGS2, SMAD3, SRC, TEK | 9.46834 |
[BP] GO:0042592 | homeostatic process | ADORA1, AKR1B1, APEX1, APP, AXL, BCL2, CA12, CA2, CA7, CNR1, EGFR, ESR1, FABP3, FABP4, FLT3, GAA, GBA, GPR35, HIF1A, HRH4, HTR2A, HTR2B, HTR2C, INSR, MET, PIK3CA, PIK3CB, SMAD3, SRC, TERT | 9.4325 |
[BP] GO:0043066 | negative regulation of apoptotic process | ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, EGFR, GLO1, HIF1A, HSPA1A, HTR2B, IDO1, IGF1R, KDR, MMP9, MPO, PIK3CA, PIM1, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT | 9.06596 |
[BP] GO:0009967 | positive regulation of signal transduction | ADORA1, AKR1B1, ALOX15, APP, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, FLT3, GPR35, HIF1A, HSPA1A, HTR2A, HTR2B, HTR2C, HTR6, INSR, KDR, MET, MMP12, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, XDH | 9.04691 |
[BP] GO:0019220 | regulation of phosphate metabolic process | ADORA1, ALOX15, APP, BCL2, CDC25B, DUSP3, EGFR, FABP3, FABP4, FLT3, GBA, HIF1A, HRH3, HRH4, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, IGF1R, INSR, KDR, MMP9, NUAK1, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH | 8.99774 |
[BP] GO:0051174 | regulation of phosphorus metabolic process | ADORA1, ALOX15, APP, BCL2, CDC25B, DUSP3, EGFR, FABP3, FABP4, FLT3, GBA, HIF1A, HRH3, HRH4, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, IGF1R, INSR, KDR, MMP9, NUAK1, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH | 8.92361 |
[BP] GO:0014070 | response to organic cyclic compound | ALPL, APEX1, APP, BCL2, CA2, CA9, CNR1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, FLT3, GBA, HSD11B2, HTR1B, HTR5A, PTGS2, SRC, TEK, TYR | 8.76913 |
[BP] GO:1902533 | positive regulation of intracellular signal transduction | ADORA1, AKR1B1, ALOX15, APP, AXL, BCL2, CYP1B1, EGFR, FLT3, GPR35, HSPA1A, HTR2A, HTR2B, HTR2C, HTR6, INSR, KDR, MET, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, TEK, XDH | 8.76893 |
[BP] GO:0048522 | positive regulation of cellular process | ACHE, ADORA1, AKR1B1, ALOX15, APEX1, APP, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DNMT1, DUSP3, DYRK1A, EGFR, ESR1, FABP3, FLT3, GBA, GPR35, HCAR2, HIF1A, HSPA1A, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, HTR6, IDO1, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, TOP2A, XDH | 8.76893 |
[BP] GO:0032879 | regulation of localization | ABCB1, ACHE, ADORA1, ADORA3, ALOX15, APEX1, APP, AXL, BCL2, CA2, CA7, CNR1, CSNK2A1, CYP19A1, CYP1B1, EGFR, GPR35, HCAR2, HIF1A, HRH3, HSPA1A, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, IGF1R, INSR, KDR, MET, MMP12, MMP9, PIK3CB, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT | 8.74158 |
[BP] GO:0009725 | response to hormone | AKR1B1, ALPL, APEX1, BCL2, CA2, CA9, CSNK2A1, CYP1A2, EGFR, ESR1, FABP3, FLT3, GBA, HSD11B2, HTR1B, HTR5A, INSR, PPARA, PTGS2, SRC, TEK | 8.6986 |
[BP] GO:0010035 | response to inorganic substance | AKR1B1, ALOX15, APEX1, APP, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, EGFR, FABP4, HIF1A, KDR, MMP9, PTGS2, SRC, TERT | 8.53251 |
[BP] GO:0097756 | None | ADORA1, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2 | 8.29802 |
[BP] GO:0055114 | oxidation-reduction process | AKR1B1, AKR1B10, ALOX15, ALOX5, APEX1, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DAO, GAA, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IDO1, MPO, NQO2, PTGS1, PTGS2, TYR, XDH | 7.93969 |
[BP] GO:0010817 | regulation of hormone levels | ACHE, ADORA1, AKR1B1, CNR1, CYP19A1, CYP1A1, CYP1B1, EGFR, ESR1, HCAR2, HIF1A, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HTR1A, HTR2A, HTR2C | 7.89348 |
[BP] GO:0070887 | cellular response to chemical stimulus | AKR1B1, ALOX15, ALPL, APEX1, APP, AXL, BCL2, CYP1A1, CYP1A2, CYP1B1, DNMT1, EGFR, ESR1, FABP4, FLT3, GBA, HIF1A, HSPA1A, HTR1B, IGF1R, INSR, KDR, MMP2, MMP9, PIK3CA, PTGS2, SMAD3, SRC, TERT | 7.89348 |
[BP] GO:0048584 | positive regulation of response to stimulus | ADORA1, AKR1B1, ALOX15, APP, AXL, BCL2, CNR1, CSNK2A1, CYP1B1, EGFR, FABP4, FLT3, GPR35, HIF1A, HSPA1A, HTR2A, HTR2B, HTR2C, HTR6, IDO1, INSR, KDR, MET, MMP12, MMP2, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, XDH | 7.89156 |
[BP] GO:0042493 | response to drug | ABCB1, AKR1B1, APEX1, AXL, BCL2, CA9, CNR1, CNR2, CYP1A1, CYP1B1, EGFR, FABP3, GBA, HSD11B2, HTR1B, HTR2A, HTR2B, HTR2C, KDR, PTGS2, SRC | 7.89156 |
[BP] GO:0048518 | positive regulation of biological process | ABCB1, ACHE, ADORA1, AKR1B1, ALOX15, APEX1, APP, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DNMT1, DUSP3, DYRK1A, EGFR, ESR1, FABP3, FABP4, FLT3, GBA, GPR35, HCAR2, HIF1A, HSPA1A, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, HTR6, IDO1, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, TOP2A, XDH | 7.85406 |
[BP] GO:0032502 | developmental process | ACHE, ADORA1, AKR1B1, ALOX15, ALPL, APEX1, APP, AURKB, AXL, BCL2, CA2, CA9, CBR1, CDC25B, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, DYRK1A, EGFR, ESR1, FABP4, FLT3, FUT7, GAA, GBA, GLO1, HIF1A, HSD11B1, HSD17B2, HTR2A, HTR2B, HTR5A, INSR, KDR, MET, MMP2, MMP9, MPO, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, SMAD3, SRC, TEK, TERT, TOP2A, TYR | 7.85272 |
[BP] GO:0009628 | response to abiotic stimulus | ADORA1, AKR1B1, APP, AURKB, BCL2, CA2, CYP1A1, EGFR, GBA, HIF1A, HSD11B2, HSPA1A, HTR1B, HTR2A, HTR2B, MMP2, MPO, PPARA, PTGS2, SMAD3, SRC, TEK, TERT, TYR | 7.82288 |
[BP] GO:0051049 | regulation of transport | ABCB1, ACHE, ADORA1, ALOX15, APP, AXL, BCL2, CA2, CA7, CNR1, CYP19A1, EGFR, GPR35, HCAR2, HIF1A, HRH3, HSPA1A, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, INSR, MMP12, MMP9, PIK3CB, PPARA, PTGS2, PTPN1, SMAD3, SRC, TERT | 7.69803 |
[BP] GO:0048583 | regulation of response to stimulus | ABCB1, ADORA1, AKR1B1, ALOX15, APP, AURKB, AXL, BCL2, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DUSP3, DYRK1A, EGFR, ESR1, FABP4, FLT3, GBA, GPR35, HIF1A, HRH4, HSPA1A, HTR1B, HTR2A, HTR2B, HTR2C, HTR6, IDO1, IGF1R, INSR, KDR, MET, MMP12, MMP2, MMP9, NUAK1, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, XDH | 7.60199 |
[BP] GO:0007187 | None | ADORA1, CNR1, CNR2, HRH3, HTR1A, HTR1B, HTR1D, HTR1E, HTR4, HTR5A, HTR6, HTR7 | 7.58418 |
[BP] GO:0048878 | chemical homeostasis | AKR1B1, APP, BCL2, CA12, CA2, CA7, CNR1, EGFR, ESR1, FABP3, FABP4, GBA, GPR35, HIF1A, HRH4, HTR2A, HTR2B, HTR2C, INSR, MET, PIK3CA, PIK3CB, SMAD3 | 7.56679 |
[BP] GO:0048523 | negative regulation of cellular process | ACHE, ADORA1, ADORA3, AKR1B1, APEX1, APP, AURKB, AXL, BCL2, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DNMT1, DUSP3, DYRK1A, EGFR, ESR1, FABP3, FABP4, GBA, GLO1, GPR35, HIF1A, HRH3, HRH4, HSPA1A, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, IDO1, IGF1R, KDR, MET, MMP12, MMP9, MPO, PIK3CA, PIM1, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, TOP2A, XDH | 7.47998 |
[BP] GO:0080134 | regulation of response to stress | ABCB1, ADORA1, APP, CNR1, CNR2, CYP19A1, DUSP3, DYRK1A, EGFR, ESR1, FABP4, GBA, HIF1A, HSPA1A, IDO1, IGF1R, MET, MMP12, MMP2, NUAK1, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, XDH | 7.40136 |
[BP] GO:0008284 | positive regulation of cell proliferation | AKR1B1, BCL2, CDC25B, CSNK2A1, EGFR, ESR1, FLT3, HIF1A, HTR1A, HTR1B, HTR2A, HTR2B, IGF1R, INSR, KDR, MMP12, MMP2, MMP9, PIM1, PTGS2, TEK, TERT | 7.31842 |
[BP] GO:0008152 | metabolic process | ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, APEX1, APP, AURKB, AXL, BACE1, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CBR1, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DAO, DNMT1, DUSP3, DYRK1A, EGFR, ESR1, FABP3, FABP4, FLT3, FUCA1, FUT7, GAA, GBA, GLO1, HIF1A, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, HTR1A, HTR1B, HTR2B, HTR2C, IDO1, IGF1R, INSR, KDR, MET, MGAM, MMP1, MMP12, MMP2, MMP9, MPO, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, TOP2A, TYR, XDH | 7.24007 |
[BP] GO:0003018 | None | ADORA1, EGFR, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2, SRC, TEK | 7.19844 |
[BP] GO:0007186 | G-protein coupled receptor signaling pathway | ADORA1, ADORA3, APP, CA2, CNR1, CNR2, ESR1, GPR35, HCAR2, HRH3, HRH4, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, INSR, PIK3CA, PIK3CB, SRC | 7.18128 |
[BP] GO:0010562 | positive regulation of phosphorus metabolic process | ADORA1, ALOX15, APP, BCL2, CDC25B, EGFR, FABP3, FLT3, GBA, HIF1A, HTR2A, HTR2B, HTR2C, INSR, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH | 7.08964 |
[BP] GO:0045937 | positive regulation of phosphate metabolic process | ADORA1, ALOX15, APP, BCL2, CDC25B, EGFR, FABP3, FLT3, GBA, HIF1A, HTR2A, HTR2B, HTR2C, INSR, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH | 7.08964 |
[BP] GO:0048519 | negative regulation of biological process | ACHE, ADORA1, ADORA3, AKR1B1, ALOX15, APEX1, APP, AURKB, AXL, BCL2, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DNMT1, DUSP3, DYRK1A, EGFR, ESR1, FABP3, FABP4, GBA, GLO1, GPR35, HCAR2, HIF1A, HRH3, HRH4, HSPA1A, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, IDO1, IGF1R, KDR, MET, MMP12, MMP9, MPO, PIK3CA, PIM1, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, TOP2A, XDH | 7.06835 |
[BP] GO:0071310 | cellular response to organic substance | AKR1B1, ALOX15, ALPL, APEX1, APP, AXL, BCL2, CYP1A1, CYP1B1, DNMT1, EGFR, ESR1, FABP4, FLT3, GBA, HIF1A, HTR1B, IGF1R, INSR, KDR, MMP2, PIK3CA, PTGS2, SMAD3, SRC | 6.98687 |
[BP] GO:0007198 | None | HTR1A, HTR1B, HTR5A, HTR7 | 6.86851 |
[BP] GO:0006950 | response to stress | ACHE, ADORA1, ADORA3, AKR1B1, ALOX15, APEX1, APP, AXL, BCL2, CA2, CA9, CNR2, CYP1A1, CYP1A2, CYP1B1, EGFR, GBA, HIF1A, HRH4, HSD11B2, HSPA1A, HTR1A, HTR2C, IDO1, MMP2, MMP9, MPO, NUAK1, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, TOP2A | 6.78582 |
[BP] GO:0050790 | regulation of catalytic activity | ADORA1, ADORA3, APP, AURKB, BCL2, CDC25B, CNR1, CNR2, CSNK2A1, DUSP3, EGFR, ESR1, FABP4, FLT3, GBA, HIF1A, HRH3, HRH4, HSPA1A, HTR2A, HTR2B, IGF1R, INSR, MMP9, NUAK1, PIK3CA, PIK3CB, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, XDH | 6.74075 |
[BP] GO:0044237 | cellular metabolic process | ACHE, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, APEX1, APP, AURKB, AXL, BACE1, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CBR1, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DAO, DNMT1, DUSP3, DYRK1A, EGFR, ESR1, FABP3, FABP4, FLT3, FUCA1, FUT7, GAA, GBA, GLO1, HIF1A, HSD17B1, HSD17B2, HSPA1A, HTR1A, HTR1B, HTR2B, HTR2C, IDO1, IGF1R, INSR, KDR, MET, MGAM, MMP1, MMP2, MPO, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, TOP2A, TYR, XDH | 6.66003 |
[BP] GO:0032844 | regulation of homeostatic process | ADORA1, AURKB, BCL2, CA2, CA7, CNR1, EGFR, HCAR2, HIF1A, HTR2A, HTR2B, HTR2C, KDR, PIK3CB, PTGS2, SRC | 6.63263 |
[BP] GO:0043408 | regulation of MAPK cascade | ADORA1, ALOX15, APP, DUSP3, EGFR, FLT3, GBA, HRH4, HTR2A, HTR2B, HTR2C, IGF1R, INSR, KDR, PIK3CB, PTPN1, SRC, TEK, XDH | 6.52788 |
[BP] GO:0042325 | regulation of phosphorylation | ADORA1, ALOX15, APP, BCL2, CDC25B, DUSP3, EGFR, FABP4, FLT3, GBA, HIF1A, HRH4, HTR2A, HTR2B, HTR2C, IGF1R, INSR, KDR, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, SRC, TEK, XDH | 6.51772 |
[BP] GO:1903727 | positive regulation of phospholipid metabolic process | FABP3, FLT3, HTR2A, HTR2B, HTR2C, SRC, TEK | 6.49114 |
[BP] GO:0015701 | bicarbonate transport | CA1, CA12, CA14, CA2, CA4, CA7, CA9 | 6.42713 |
[BP] GO:0031399 | regulation of protein modification process | ADORA1, ALOX15, APP, BCL2, CDC25B, DNMT1, DUSP3, DYRK1A, EGFR, FABP4, FLT3, GBA, HRH4, HSPA1A, HTR2A, HTR2B, HTR2C, IGF1R, INSR, KDR, MMP9, NUAK1, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, TEK, XDH | 6.31782 |
[BP] GO:0009966 | regulation of signal transduction | ADORA1, AKR1B1, ALOX15, APP, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DUSP3, DYRK1A, EGFR, ESR1, FLT3, GBA, GPR35, HIF1A, HRH4, HSPA1A, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, INSR, KDR, MET, MMP12, MMP9, NUAK1, PIK3CA, PIK3CB, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, XDH | 6.29631 |
[BP] GO:0008202 | steroid metabolic process | AKR1B1, AKR1B10, APP, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 | 6.25684 |
[BP] GO:0046777 | protein autophosphorylation | AURKB, CSNK2A1, DYRK1A, EGFR, FLT3, IGF1R, INSR, KDR, PIM1, SRC, TEK | 6.23089 |
[BP] GO:0010243 | response to organonitrogen compound | AKR1B1, APEX1, APP, CNR1, CNR2, DNMT1, EGFR, FABP3, FLT3, HSD11B2, HTR1B, IGF1R, INSR, MMP2, PPARA, PTGS2, SRC, TEK, TYR | 6.16392 |
[BP] GO:0030334 | regulation of cell migration | ADORA1, ADORA3, APEX1, APP, BCL2, CYP19A1, CYP1B1, EGFR, HIF1A, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK, TERT | 6.06172 |
[BP] GO:0001666 | response to hypoxia | ADORA1, BCL2, CYP1A1, HIF1A, HSD11B2, MMP2, PPARA, PTGS2, SMAD3, SRC, TEK, TERT | 6.05644 |
[BP] GO:0003013 | None | ADORA1, EGFR, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2, SRC, TEK | 6.05644 |
[BP] GO:0042310 | None | HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7 | 6.02089 |
[BP] GO:0019748 | secondary metabolic process | AKR1B1, AKR1B10, BCL2, CYP1A1, CYP1A2, CYP1B1, TYR | 6.02032 |
[BP] GO:0044255 | cellular lipid metabolic process | ACHE, AKR1B10, ALOX15, ALOX5, CBR1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, FABP3, FABP4, FUCA1, FUT7, GBA, MET, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2 | 6.01939 |
[BP] GO:0006796 | phosphate-containing compound metabolic process | ACHE, ALOX15, ALPL, APEX1, APP, AURKB, AXL, BCL2, CDC25B, CSNK2A1, DUSP3, DYRK1A, EGFR, FLT3, HSPA1A, HTR2B, HTR2C, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIK3CB, PIM1, PTGS2, PTPN1, SRC, TEK, XDH | 6.00911 |
[BP] GO:0001932 | regulation of protein phosphorylation | ADORA1, ALOX15, APP, BCL2, CDC25B, DUSP3, EGFR, FABP4, FLT3, GBA, HRH4, HTR2A, HTR2B, HTR2C, IGF1R, INSR, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, TEK, XDH | 6.0014 |
[BP] GO:0036293 | response to decreased oxygen levels | ADORA1, BCL2, CYP1A1, HIF1A, HSD11B2, MMP2, PPARA, PTGS2, SMAD3, SRC, TEK, TERT | 5.93513 |
[BP] GO:0010648 | negative regulation of cell communication | ACHE, ADORA1, BCL2, CNR2, DUSP3, DYRK1A, EGFR, ESR1, GBA, GPR35, HIF1A, HSPA1A, HTR1B, HTR2A, IGF1R, MET, MMP12, MMP9, PTGS2, PTPN1, SMAD3, SRC, TERT, XDH | 5.93002 |
[BP] GO:0051247 | positive regulation of protein metabolic process | ADORA1, ALOX15, APP, BCL2, CDC25B, CSNK2A1, DNMT1, DYRK1A, EGFR, ESR1, FLT3, GBA, HSPA1A, HTR2A, HTR2B, HTR2C, INSR, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH | 5.92824 |
[BP] GO:0051716 | cellular response to stimulus | AKR1B1, ALOX15, ALPL, APEX1, APP, AURKB, AXL, BCL2, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DNMT1, EGFR, ESR1, FABP4, FLT3, GBA, HIF1A, HSPA1A, HTR1B, IGF1R, INSR, KDR, MMP2, MMP9, NUAK1, PIK3CA, PTGS2, PTPN1, SMAD3, SRC, TERT, TOP2A | 5.92824 |
[BP] GO:0023057 | negative regulation of signaling | ACHE, ADORA1, BCL2, CNR2, DUSP3, DYRK1A, EGFR, ESR1, GBA, GPR35, HIF1A, HSPA1A, HTR1B, HTR2A, IGF1R, MET, MMP12, MMP9, PTGS2, PTPN1, SMAD3, SRC, TERT, XDH | 5.91529 |
[BP] GO:0065009 | regulation of molecular function | ABCB1, ADORA1, ADORA3, APP, AURKB, BCL2, CDC25B, CNR1, CNR2, CSNK2A1, CYP1B1, DUSP3, EGFR, ESR1, FABP4, FLT3, GBA, GPR35, HIF1A, HRH3, HRH4, HSPA1A, HTR2A, HTR2B, IGF1R, INSR, MET, MMP9, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, XDH | 5.88442 |
[BP] GO:0040012 | regulation of locomotion | ADORA1, ADORA3, APEX1, APP, BCL2, CYP19A1, CYP1B1, EGFR, HIF1A, HTR1D, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK, TERT | 5.88368 |
[BP] GO:0019369 | arachidonic acid metabolic process | ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1, PTGS1, PTGS2 | 5.88368 |
[BP] GO:0042327 | positive regulation of phosphorylation | ADORA1, ALOX15, APP, BCL2, CDC25B, EGFR, FLT3, HIF1A, HTR2A, HTR2B, HTR2C, INSR, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, TEK, XDH | 5.867 |
[BP] GO:0045834 | positive regulation of lipid metabolic process | FABP3, FLT3, HTR2A, HTR2B, HTR2C, PPARA, PTGS2, SRC, TEK | 5.84224 |
[BP] GO:0097746 | None | ADORA1, EGFR, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2 | 5.82204 |
[BP] GO:0035296 | None | ADORA1, EGFR, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2 | 5.82204 |
[BP] GO:0032228 | regulation of synaptic transmission, GABAergic | ADORA1, CA2, CA7, CNR1, CNR2, HTR1B | 5.81414 |
[BP] GO:0032270 | positive regulation of cellular protein metabolic process | ADORA1, ALOX15, APP, BCL2, CDC25B, DNMT1, DYRK1A, EGFR, ESR1, FLT3, GBA, HSPA1A, HTR2A, HTR2B, HTR2C, INSR, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH | 5.81277 |
[BP] GO:0031401 | positive regulation of protein modification process | ADORA1, ALOX15, APP, BCL2, CDC25B, DNMT1, DYRK1A, EGFR, FLT3, GBA, HTR2A, HTR2B, HTR2C, INSR, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, TEK, XDH | 5.77355 |
[BP] GO:0006979 | response to oxidative stress | AKR1B1, APEX1, APP, AXL, BCL2, CYP1B1, EGFR, HSPA1A, MMP9, MPO, PTGS1, PTGS2, SRC | 5.7596 |
[BP] GO:1901698 | response to nitrogen compound | AKR1B1, APEX1, APP, CNR1, CNR2, DNMT1, EGFR, FABP3, FLT3, HSD11B2, HTR1B, IGF1R, INSR, MMP2, PPARA, PTGS2, SRC, TEK, TYR | 5.73183 |
[BP] GO:0009894 | regulation of catabolic process | ADORA1, APEX1, BCL2, CNR1, CSNK2A1, EGFR, GBA, HCAR2, HIF1A, HSPA1A, HTR2A, HTR2B, INSR, KDR, MET, PIK3CA, PIK3CB, PPARA, PTPN1, SMAD3 | 5.73183 |
[BP] GO:2000145 | regulation of cell motility | ADORA1, ADORA3, APEX1, APP, BCL2, CYP19A1, CYP1B1, EGFR, HIF1A, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK, TERT | 5.72211 |
[BP] GO:0006793 | phosphorus metabolic process | ACHE, ALOX15, ALPL, APEX1, APP, AURKB, AXL, BCL2, CDC25B, CSNK2A1, DUSP3, DYRK1A, EGFR, FLT3, HSPA1A, HTR2B, HTR2C, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIK3CB, PIM1, PTGS2, PTPN1, SRC, TEK, XDH | 5.63126 |
[BP] GO:0050880 | None | ADORA1, EGFR, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2 | 5.61752 |
[BP] GO:0070482 | response to oxygen levels | ADORA1, BCL2, CYP1A1, HIF1A, HSD11B2, MMP2, PPARA, PTGS2, SMAD3, SRC, TEK, TERT | 5.6006 |
[BP] GO:0035150 | None | ADORA1, EGFR, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2 | 5.59533 |
[BP] GO:0006730 | one-carbon metabolic process | CA1, CA12, CA2, CA4, CA7, CA9 | 5.53216 |
[BP] GO:0001934 | positive regulation of protein phosphorylation | ADORA1, ALOX15, APP, BCL2, CDC25B, EGFR, FLT3, HTR2A, HTR2B, HTR2C, INSR, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, TEK, XDH | 5.51237 |
[BP] GO:0019216 | regulation of lipid metabolic process | ADORA1, CNR1, CYP1A1, FABP3, FLT3, HCAR2, HTR2A, HTR2B, HTR2C, PPARA, PTGS2, SRC, TEK | 5.50737 |
[BP] GO:0009056 | catabolic process | ACHE, ADORA1, AKR1B10, AURKB, BACE1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DAO, FABP3, FABP4, FUCA1, FUT7, GAA, GBA, HSPA1A, IDO1, MGAM, MMP1, MMP12, MMP2, MMP9, MPO, PIK3CB, SRC, XDH | 5.50591 |
[BP] GO:0042445 | hormone metabolic process | ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 | 5.49302 |
[BP] GO:0043410 | positive regulation of MAPK cascade | ADORA1, ALOX15, APP, EGFR, FLT3, HTR2A, HTR2B, HTR2C, INSR, KDR, PIK3CB, PTPN1, SRC, TEK, XDH | 5.49302 |
[BP] GO:0033559 | unsaturated fatty acid metabolic process | ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, PTGS1, PTGS2 | 5.48264 |
[BP] GO:0018108 | peptidyl-tyrosine phosphorylation | AXL, DYRK1A, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK | 5.48264 |
[BP] GO:0048585 | negative regulation of response to stimulus | ADORA1, ALOX15, BCL2, CNR1, CNR2, CYP19A1, DUSP3, DYRK1A, EGFR, ESR1, GBA, HIF1A, HSPA1A, IGF1R, MET, MMP12, MMP9, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, XDH | 5.48159 |
[BP] GO:0050804 | modulation of chemical synaptic transmission | ACHE, ADORA1, APP, BACE1, CA2, CA7, CNR1, CNR2, EGFR, HTR1B, HTR2A, PTGS2 | 5.48159 |
[BP] GO:0099177 | regulation of trans-synaptic signaling | ACHE, ADORA1, APP, BACE1, CA2, CA7, CNR1, CNR2, EGFR, HTR1B, HTR2A, PTGS2 | 5.48159 |
[BP] GO:0050795 | None | ADORA1, CNR1, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B | 5.45768 |
[BP] GO:0030335 | positive regulation of cell migration | APP, BCL2, EGFR, HIF1A, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK, TERT | 5.43527 |
[BP] GO:0018212 | peptidyl-tyrosine modification | AXL, DYRK1A, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK | 5.43427 |
[BP] GO:0044092 | negative regulation of molecular function | ADORA3, APP, AURKB, CNR1, CNR2, CSNK2A1, CYP1B1, DUSP3, ESR1, FABP4, GBA, GPR35, HRH3, HRH4, IGF1R, MET, MMP9, PIM1, PPARA, PTGS2, PTPN1, SRC | 5.43106 |
[BP] GO:0043271 | negative regulation of ion transport | ADORA1, BCL2, CNR1, GPR35, HRH3, HTR1B, HTR2A, MMP9, PTGS2 | 5.42844 |
[BP] GO:0009892 | negative regulation of metabolic process | ADORA1, APEX1, APP, AURKB, BCL2, CNR1, CNR2, CSNK2A1, DNMT1, DUSP3, DYRK1A, EGFR, ESR1, FABP4, GBA, HCAR2, HIF1A, HRH3, HRH4, HSPA1A, HTR1B, HTR1E, HTR2B, IGF1R, KDR, MET, MMP12, MMP9, PIK3CA, PPARA, PTGS2, PTPN1, SMAD3, SRC, TERT, XDH | 5.42579 |
[BP] GO:0003008 | None | ADORA1, AKR1B1, APP, BCL2, CNR1, CNR2, CYP1B1, EGFR, GAA, HIF1A, HRH3, HSD11B2, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, INSR, PIK3CA, PTGS2, SRC, TEK, TYR | 5.42579 |
[BP] GO:0031347 | regulation of defense response | ADORA1, CNR1, CNR2, CYP19A1, EGFR, ESR1, FABP4, GBA, HSPA1A, IDO1, MMP12, MMP2, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK | 5.3268 |
[BP] GO:0048513 | animal organ development | ACHE, AXL, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, EGFR, ESR1, FLT3, HIF1A, HSD11B1, HSD17B2, INSR, KDR, PIK3CA, PPARA, SMAD3, SRC, TEK, TYR | 5.31674 |
[BP] GO:0006690 | icosanoid metabolic process | ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, PTGS1, PTGS2 | 5.2865 |
[BP] GO:2000147 | positive regulation of cell motility | APP, BCL2, EGFR, HIF1A, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK, TERT | 5.27102 |
[BP] GO:0010038 | response to metal ion | ALOX15, APP, BCL2, CA2, CYP1A1, CYP1A2, EGFR, FABP4, HIF1A, MMP9, PTGS2, TERT | 5.24282 |
[BP] GO:0051270 | regulation of cellular component movement | ADORA1, ADORA3, APEX1, APP, BCL2, CYP19A1, CYP1B1, EGFR, HIF1A, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK, TERT | 5.24282 |
[BP] GO:0007610 | None | APP, BCL2, CNR1, EGFR, GAA, HIF1A, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, IDO1, INSR, PPARA, PTGS2 | 5.23977 |
[BP] GO:0050727 | regulation of inflammatory response | ADORA1, CNR1, CNR2, CYP19A1, EGFR, ESR1, FABP4, GBA, IDO1, PPARA, PTGS2, SMAD3, TEK | 5.23977 |
[BP] GO:1903725 | regulation of phospholipid metabolic process | FABP3, FLT3, HTR2A, HTR2B, HTR2C, SRC, TEK | 5.14082 |
[BP] GO:0051272 | positive regulation of cellular component movement | APP, BCL2, EGFR, HIF1A, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK, TERT | 5.1364 |
[BP] GO:0008610 | lipid biosynthetic process | ACHE, AKR1B1, ALOX15, CSNK2A1, CYP19A1, CYP1A1, GBA, HSD11B1, HSD11B2, HSD17B1, HSD17B2, PIK3CA, PIK3CB, PTGS1, PTGS2 | 5.11284 |
[BP] GO:0031960 | response to corticosteroid | ALPL, BCL2, EGFR, FLT3, GBA, HSD11B2, HTR1B, PTGS2, SRC | 5.11276 |
[BP] GO:0071073 | None | FABP3, HTR2A, HTR2B, HTR2C | 5.09298 |
[BP] GO:0050999 | None | CNR1, CNR2, EGFR, HIF1A, HTR2B, TERT | 5.08073 |
[BP] GO:0009636 | response to toxic substance | AKR1B1, ALPL, APEX1, AXL, BCL2, CNR1, CNR2, CYP1A1, CYP1B1, HTR1B, HTR1D, KDR, SRC | 5.07848 |
[BP] GO:0007193 | None | ADORA1, HTR1A, HTR1B, HTR1D, HTR1E, HTR5A, HTR7 | 4.99934 |
[BP] GO:0048661 | positive regulation of smooth muscle cell proliferation | AKR1B1, EGFR, HTR1B, MMP2, MMP9, PTGS2, TERT | 4.99934 |
[BP] GO:0070372 | regulation of ERK1 and ERK2 cascade | ALOX15, APP, DUSP3, EGFR, HTR2A, HTR2B, HTR2C, KDR, PTPN1, SRC, TEK | 4.98114 |
[BP] GO:0043405 | regulation of MAP kinase activity | ADORA1, DUSP3, EGFR, FLT3, GBA, HTR2A, HTR2B, IGF1R, INSR, PIK3CB, PTPN1, SRC | 4.97736 |
[BP] GO:0040017 | positive regulation of locomotion | APP, BCL2, EGFR, HIF1A, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK, TERT | 4.97451 |
[BP] GO:0006468 | protein phosphorylation | APP, AURKB, AXL, BCL2, CDC25B, CSNK2A1, DYRK1A, EGFR, FLT3, HTR2B, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIM1, SRC, TEK | 4.9639 |
[BP] GO:1901615 | organic hydroxy compound metabolic process | AKR1B1, AKR1B10, ALOX15, APP, BCL2, CYP19A1, CYP1A1, CYP1B1, DAO, GBA, HIF1A, HTR1A, TYR | 4.9502 |
[BP] GO:0051173 | positive regulation of nitrogen compound metabolic process | ADORA1, ALOX15, APP, AURKB, BCL2, CDC25B, CSNK2A1, DNMT1, DYRK1A, EGFR, ESR1, FLT3, GBA, HIF1A, HSPA1A, HTR2A, HTR2B, HTR2C, IGF1R, INSR, KDR, MET, MMP12, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, TOP2A, XDH | 4.91796 |
[BP] GO:0048545 | response to steroid hormone | ALPL, BCL2, CA2, EGFR, FLT3, GBA, HSD11B2, HTR1B, PTGS2, SRC | 4.91014 |
[BP] GO:0071704 | organic substance metabolic process | ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, APEX1, APP, AURKB, AXL, BACE1, BCL2, CBR1, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DAO, DNMT1, DUSP3, DYRK1A, EGFR, ESR1, FABP3, FABP4, FLT3, FUCA1, FUT7, GAA, GBA, GLO1, HIF1A, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, HTR1A, HTR1B, HTR2B, HTR2C, IDO1, IGF1R, INSR, KDR, MET, MGAM, MMP1, MMP12, MMP2, MMP9, MPO, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, TOP2A, TYR, XDH | 4.90968 |
[BP] GO:0007165 | signal transduction | ADORA1, ADORA3, AKR1B1, APP, AXL, BCL2, CA1, CA2, CNR1, CNR2, CSNK2A1, CYP1B1, DNMT1, EGFR, ESR1, FLT3, GPR35, HCAR2, HIF1A, HRH3, HRH4, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, MMP2, MMP9, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTPN1, SMAD3, SRC, TEK | 4.87264 |
[BP] GO:0007169 | transmembrane receptor protein tyrosine kinase signaling pathway | AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, MMP2, MMP9, PIK3CA, PIK3CB, PTPN1, SRC, TEK | 4.87264 |
[BP] GO:0050801 | ion homeostasis | APP, BCL2, CA12, CA2, CA7, EGFR, ESR1, FABP3, GPR35, HIF1A, HRH4, HTR2A, HTR2B, HTR2C, PIK3CB, SMAD3 | 4.86001 |
[BP] GO:1902532 | negative regulation of intracellular signal transduction | BCL2, DUSP3, DYRK1A, ESR1, GBA, HIF1A, HSPA1A, IGF1R, MET, MMP9, PTGS2, PTPN1, SRC, XDH | 4.69412 |
[BP] GO:0051240 | positive regulation of multicellular organismal process | APP, AXL, BCL2, CA2, CNR1, CYP1B1, EGFR, GBA, HCAR2, HIF1A, HSPA1A, HTR2A, HTR2B, IDO1, KDR, MET, MMP12, MMP9, PIM1, PTGS2, SMAD3, SRC, TEK, TERT | 4.68496 |
[BP] GO:0065007 | biological regulation | ABCB1, ACHE, ADORA1, ADORA3, AKR1B1, ALOX15, APEX1, APP, AURKB, AXL, BACE1, BCL2, CA1, CA12, CA2, CA7, CA9, CDC25B, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DUSP3, DYRK1A, EGFR, ESR1, FABP3, FABP4, FLT3, GAA, GBA, GLO1, GPR35, HCAR2, HIF1A, HRH3, HRH4, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IDO1, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, MPO, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, TOP2A, XDH | 4.57891 |
[BP] GO:0032768 | None | CNR1, CNR2, EGFR, HIF1A, HTR2B, TERT | 4.53656 |
[BP] GO:0009987 | cellular process | ABCB1, ACHE, ADORA1, ADORA3, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, APEX1, APP, AURKB, AXL, BACE1, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CBR1, CDC25B, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DAO, DNMT1, DUSP3, DYRK1A, EGFR, ESR1, FABP3, FABP4, FLT3, FUCA1, FUT7, GAA, GBA, GLO1, GPR35, HCAR2, HIF1A, HRH3, HRH4, HSD17B1, HSD17B2, HSPA1A, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IDO1, IGF1R, INSR, KDR, MET, MGAM, MMP1, MMP12, MMP2, MMP9, MPO, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, TOP2A, TYR, XDH | 4.4843 |
[BP] GO:0014065 | phosphatidylinositol 3-kinase signaling | HTR2A, HTR2B, IGF1R, PIK3CA, PIK3CB | 4.3992 |
[BP] GO:0031325 | positive regulation of cellular metabolic process | ADORA1, ALOX15, APP, AURKB, BCL2, CDC25B, DNMT1, DYRK1A, EGFR, ESR1, FABP3, FLT3, GBA, HIF1A, HSPA1A, HTR2A, HTR2B, HTR2C, IGF1R, INSR, KDR, MET, MMP12, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, TOP2A, XDH | 4.39261 |
[BP] GO:2001243 | negative regulation of intrinsic apoptotic signaling pathway | BCL2, HIF1A, HSPA1A, MMP9, PTGS2, PTPN1, SRC | 4.38426 |
[BP] GO:0051966 | regulation of synaptic transmission, glutamatergic | ADORA1, CNR1, EGFR, HTR1B, HTR2A, PTGS2 | 4.37001 |
[BP] GO:0010604 | positive regulation of macromolecule metabolic process | ADORA1, ALOX15, APP, AURKB, BCL2, CDC25B, CSNK2A1, DNMT1, DYRK1A, EGFR, ESR1, FLT3, GBA, HIF1A, HSPA1A, HTR2A, HTR2B, HTR2C, IGF1R, INSR, KDR, MET, MMP12, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, TOP2A, XDH | 4.37001 |
[BP] GO:0098771 | inorganic ion homeostasis | APP, BCL2, CA12, CA2, CA7, EGFR, ESR1, GPR35, HIF1A, HRH4, HTR2A, HTR2B, HTR2C, PIK3CB, SMAD3 | 4.35087 |
[BP] GO:0032847 | regulation of cellular pH reduction | BCL2, CA2, CA7 | 4.33323 |
[BP] GO:0070374 | positive regulation of ERK1 and ERK2 cascade | ALOX15, APP, EGFR, HTR2A, HTR2B, HTR2C, KDR, SRC, TEK | 4.30971 |
[BP] GO:0042446 | hormone biosynthetic process | AKR1B1, CYP19A1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 | 4.29598 |
[BP] GO:0016310 | phosphorylation | APP, AURKB, AXL, BCL2, CDC25B, CSNK2A1, DYRK1A, EGFR, FLT3, HTR2B, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIK3CB, PIM1, SRC, TEK | 4.29598 |
[BP] GO:0032787 | None | ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, FABP3, GLO1, HIF1A, IDO1, PPARA, PTGS1, PTGS2 | 4.28905 |
[BP] GO:0032268 | regulation of cellular protein metabolic process | ADORA1, ALOX15, APP, BCL2, CDC25B, CSNK2A1, DNMT1, DUSP3, DYRK1A, EGFR, ESR1, FABP4, FLT3, GBA, HRH4, HSPA1A, HTR2A, HTR2B, HTR2C, IGF1R, INSR, KDR, MMP9, NUAK1, PIK3CA, PIK3CB, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH | 4.28199 |
[BP] GO:0008283 | cell proliferation | ABCB1, ACHE, AURKB, BCL2, CYP1A1, EGFR, ESR1, FLT3, HTR1A, MET, PIK3CB, PIM1, SRC, TEK, TYR | 4.26839 |
[BP] GO:0001676 | long-chain fatty acid metabolic process | ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1, PTGS1, PTGS2 | 4.26158 |
[BP] GO:0044238 | primary metabolic process | ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, APEX1, APP, AURKB, AXL, BACE1, BCL2, CBR1, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DAO, DNMT1, DUSP3, DYRK1A, EGFR, ESR1, FABP3, FABP4, FLT3, FUCA1, FUT7, GAA, GBA, GLO1, HIF1A, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, HTR2B, HTR2C, IDO1, IGF1R, INSR, KDR, MET, MGAM, MMP1, MMP12, MMP2, MMP9, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, TOP2A, TYR, XDH | 4.26109 |
[BP] GO:0009895 | negative regulation of catabolic process | ADORA1, BCL2, CNR1, EGFR, HCAR2, HTR2B, MET, PIK3CA, PPARA, SMAD3 | 4.24784 |
[BP] GO:0043549 | regulation of kinase activity | ADORA1, APP, CDC25B, DUSP3, EGFR, FABP4, FLT3, GBA, HTR2A, HTR2B, IGF1R, INSR, PIK3CA, PIK3CB, PTPN1, SRC, TEK | 4.24451 |
[BP] GO:0009893 | positive regulation of metabolic process | ADORA1, ALOX15, APP, AURKB, BCL2, CDC25B, CSNK2A1, DNMT1, DYRK1A, EGFR, ESR1, FABP3, FLT3, GBA, HIF1A, HSPA1A, HTR2A, HTR2B, HTR2C, IGF1R, INSR, KDR, MET, MMP12, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, TOP2A, XDH | 4.24194 |
[BP] GO:0051130 | positive regulation of cellular component organization | ALOX15, APP, AURKB, AXL, BCL2, CNR1, DNMT1, ESR1, GBA, HIF1A, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP9, SMAD3, SRC, TEK | 4.20708 |
[BP] GO:0050805 | negative regulation of synaptic transmission | ACHE, ADORA1, CNR2, HTR1B, HTR2A, PTGS2 | 4.19669 |
[BP] GO:0051050 | positive regulation of transport | ABCB1, ACHE, ADORA1, APP, AXL, BCL2, CA2, CYP19A1, EGFR, HCAR2, HIF1A, HTR2B, INSR, MMP12, PTGS2, SMAD3, SRC, TERT | 4.16707 |
[BP] GO:0051897 | positive regulation of protein kinase B signaling | AXL, EGFR, INSR, MET, PIK3CA, PIK3CB, SRC, TEK | 4.153 |
[BP] GO:2000021 | regulation of ion homeostasis | ADORA1, BCL2, CA2, CA7, HTR2A, HTR2B, HTR2C, KDR, SRC | 4.14671 |
[BP] GO:0007167 | enzyme linked receptor protein signaling pathway | AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, MMP2, MMP9, PIK3CA, PIK3CB, PTPN1, SMAD3, SRC, TEK | 4.12825 |
[BP] GO:0051896 | regulation of protein kinase B signaling | AXL, EGFR, INSR, MET, PIK3CA, PIK3CB, SRC, TEK, XDH | 4.09868 |
[BP] GO:1901568 | fatty acid derivative metabolic process | ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, PTGS1, PTGS2 | 4.09646 |
[BP] GO:1901564 | organonitrogen compound metabolic process | ACHE, AKR1B1, ALPL, APP, AURKB, AXL, BACE1, BCL2, CDC25B, CSNK2A1, CYP1A1, CYP1A2, DAO, DUSP3, DYRK1A, EGFR, ESR1, FLT3, FUCA1, FUT7, GBA, GLO1, HIF1A, HSPA1A, HTR1A, HTR2B, HTR2C, IDO1, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIK3CA, PIM1, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TOP2A, TYR, XDH | 4.07917 |
[BP] GO:0007188 | None | ADORA1, CNR1, HTR1A, HTR1B, HTR1D, HTR1E, HTR5A, HTR7 | 4.07917 |
[BP] GO:1903530 | regulation of secretion by cell | ACHE, ADORA1, CNR1, CYP19A1, EGFR, HCAR2, HIF1A, HRH3, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, MMP12, SRC | 4.07521 |
[BP] GO:0071071 | None | FABP3, HTR2A, HTR2B, HTR2C | 4.07521 |
[BP] GO:0032496 | response to lipopolysaccharide | ALPL, AXL, CNR1, CNR2, CYP1A1, CYP1A2, IDO1, MPO, PTGS2, SRC | 4.07219 |
[BP] GO:0034754 | cellular hormone metabolic process | AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2 | 4.07155 |
[BP] GO:0034614 | cellular response to reactive oxygen species | AKR1B1, APEX1, AXL, CYP1B1, EGFR, MMP9, SRC | 4.07155 |
[BP] GO:0019222 | regulation of metabolic process | ACHE, ADORA1, ADORA3, ALOX15, APEX1, APP, AURKB, BCL2, CA9, CDC25B, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DUSP3, DYRK1A, EGFR, ESR1, FABP3, FABP4, FLT3, GBA, GLO1, HCAR2, HIF1A, HRH3, HRH4, HSPA1A, HTR1A, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, IGF1R, INSR, KDR, MET, MMP12, MMP9, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, TOP2A, XDH | 4.06255 |
[BP] GO:1901652 | response to peptide | AKR1B1, APEX1, APP, FABP3, HSD11B2, IGF1R, INSR, PPARA, PTGS2, SRC, TEK | 4.05883 |
[BP] GO:0051239 | regulation of multicellular organismal process | ADORA1, ADORA3, APP, AXL, BCL2, CA2, CNR1, CYP1B1, EGFR, ESR1, GAA, GBA, GPR35, HCAR2, HIF1A, HSPA1A, HTR2A, HTR2B, HTR2C, IDO1, INSR, KDR, MET, MMP12, MMP9, PIK3CA, PIM1, PTGS2, SMAD3, SRC, TEK, TERT, XDH | 4.05558 |
[BP] GO:0051701 | interaction with host | AXL, EGFR, HSPA1A, HTR2A, INSR, MET, SMAD3, SRC | 4.05433 |
[BP] GO:0080090 | regulation of primary metabolic process | ADORA1, ADORA3, ALOX15, APEX1, APP, AURKB, BCL2, CA9, CDC25B, CNR1, CSNK2A1, CYP1A1, CYP1B1, DNMT1, DUSP3, DYRK1A, EGFR, ESR1, FABP3, FABP4, FLT3, GBA, GLO1, HCAR2, HIF1A, HRH3, HRH4, HSPA1A, HTR1A, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, IGF1R, INSR, KDR, MET, MMP12, MMP9, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, TOP2A, XDH | 4.05029 |
[BP] GO:0032101 | regulation of response to external stimulus | ADORA1, CNR1, CNR2, CYP19A1, EGFR, ESR1, FABP4, GBA, IDO1, KDR, MET, MMP12, PPARA, PTGS2, SMAD3, TEK | 4.04827 |
[BP] GO:0048856 | anatomical structure development | ACHE, ADORA1, AKR1B1, ALOX15, ALPL, APP, AXL, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, DYRK1A, EGFR, ESR1, FLT3, GAA, HIF1A, HSD11B1, HSD17B2, HTR5A, INSR, KDR, MMP9, PIK3CA, PIM1, PPARA, PTGS2, SMAD3, SRC, TEK, TYR | 4.03372 |
[BP] GO:0019725 | cellular homeostasis | APEX1, APP, BCL2, CA2, CA7, ESR1, GAA, GPR35, HIF1A, HRH4, HTR2A, HTR2B, HTR2C, PIK3CA, PIK3CB, SMAD3 | 4.03202 |
[BP] GO:0045859 | regulation of protein kinase activity | ADORA1, APP, CDC25B, DUSP3, EGFR, FABP4, FLT3, GBA, HTR2A, HTR2B, IGF1R, INSR, PIK3CA, PIK3CB, PTPN1, SRC | 4.01347 |
[BP] GO:0010513 | None | HTR2A, HTR2B, HTR2C | 4.01347 |
[BP] GO:0009991 | response to extracellular stimulus | ALPL, AXL, BCL2, CNR1, CYP1A1, EGFR, GBA, HSD11B2, MPO, PTGS2, SRC, TYR | 4.00811 |
[BP] GO:0048511 | rhythmic process | AXL, BCL2, CSNK2A1, DYRK1A, EGFR, ESR1, HTR7, PPARA, SRC, TOP2A | 4.00164 |
[BP] GO:0031324 | negative regulation of cellular metabolic process | APEX1, APP, AURKB, BCL2, CNR1, CSNK2A1, DNMT1, DUSP3, DYRK1A, ESR1, FABP4, GBA, HIF1A, HRH3, HRH4, HSPA1A, HTR1B, HTR1E, HTR2B, IGF1R, MET, MMP12, MMP9, PIK3CA, PPARA, PTGS2, PTPN1, SMAD3, SRC, TERT, XDH | 3.96145 |
[BP] GO:0043269 | regulation of ion transport | ABCB1, ADORA1, APP, BCL2, CA2, CA7, CNR1, GPR35, HRH3, HTR1A, HTR1B, HTR2A, MMP9, PTGS2 | 3.95929 |
[BP] GO:0001503 | ossification | ALOX15, ALPL, BCL2, EGFR, MMP2, MMP9, TEK | 3.94192 |
[BP] GO:0050728 | negative regulation of inflammatory response | ADORA1, CNR2, CYP19A1, GBA, PPARA, SMAD3, TEK | 3.9181 |
[BP] GO:0010638 | positive regulation of organelle organization | ALOX15, AURKB, BCL2, DNMT1, GBA, HIF1A, HSPA1A, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK | 3.90618 |
[BP] GO:0032846 | positive regulation of homeostatic process | AURKB, CA2, CA7, CNR1, EGFR, HCAR2, HIF1A, PIK3CB, PTGS2 | 3.90063 |
[BP] GO:0051338 | regulation of transferase activity | ADORA1, APP, AURKB, CDC25B, DUSP3, EGFR, FABP4, FLT3, GBA, HTR2A, HTR2B, IGF1R, INSR, PIK3CA, PIK3CB, PTPN1, SRC, TEK | 3.89948 |
[BP] GO:0016137 | None | AKR1B1, AKR1B10, FUCA1, GBA | 3.89641 |
[BP] GO:0022414 | reproductive process | AKR1B1, ALPL, APP, AXL, BCL2, CDC25B, CNR1, CYP19A1, CYP1A1, EGFR, ESR1, HIF1A, HSD11B2, HSD17B2, IDO1, INSR, MMP2, MMP9, PTGS2, SRC, TOP2A | 3.89349 |
[BP] GO:2000377 | regulation of reactive oxygen species metabolic process | BCL2, CYP1B1, EGFR, HIF1A, INSR, PTGS2, SMAD3, XDH | 3.87136 |
[BP] GO:0006631 | fatty acid metabolic process | ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, FABP3, PPARA, PTGS1, PTGS2 | 3.86385 |
[BP] GO:0002237 | response to molecule of bacterial origin | ALPL, AXL, CNR1, CNR2, CYP1A1, CYP1A2, IDO1, MPO, PTGS2, SRC | 3.86385 |
[BP] GO:0031348 | negative regulation of defense response | ADORA1, CNR2, CYP19A1, GBA, MMP12, PPARA, SMAD3, TEK | 3.84043 |
[BP] GO:0007568 | aging | APEX1, AURKB, BCL2, CNR1, CYP1A1, HTR2A, MPO, PTGS2, TERT | 3.84043 |
[BP] GO:0055080 | cation homeostasis | APP, BCL2, CA2, CA7, EGFR, ESR1, GPR35, HIF1A, HRH4, HTR2A, HTR2B, HTR2C, PIK3CB, SMAD3 | 3.82235 |
[BP] GO:0044093 | positive regulation of molecular function | ABCB1, ADORA1, APP, AURKB, BCL2, CDC25B, EGFR, ESR1, FLT3, HIF1A, HSPA1A, HTR2A, HTR2B, INSR, MET, MMP9, PIK3CA, PIK3CB, PTPN1, SMAD3, SRC, TEK, TERT, XDH | 3.82235 |
[BP] GO:0000302 | response to reactive oxygen species | AKR1B1, APEX1, AXL, BCL2, CYP1B1, EGFR, MMP9, SRC | 3.78985 |
[BP] GO:0032229 | None | ADORA1, CNR2, HTR1B | 3.75519 |
[BP] GO:0051046 | None | ACHE, ADORA1, CNR1, CYP19A1, EGFR, HCAR2, HIF1A, HRH3, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, MMP12, SRC | 3.74945 |
[BP] GO:0016477 | cell migration | AXL, CNR2, CYP1B1, EGFR, FUT7, HIF1A, HTR2B, HTR6, KDR, MMP1, MMP12, MMP9, PIK3CA, PIK3CB, SRC, TEK | 3.73923 |
[BP] GO:0010634 | positive regulation of epithelial cell migration | HIF1A, KDR, MET, MMP9, PTGS2, SRC, TEK | 3.71039 |
[BP] GO:0009611 | response to wounding | ACHE, ADORA3, ALOX15, BCL2, CYP1A1, EGFR, PPARA, SMAD3 | 3.70772 |
[BP] GO:0043436 | oxoacid metabolic process | ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, DAO, FABP3, GLO1, HIF1A, IDO1, MPO, PIM1, PPARA, PTGS1, PTGS2, TYR | 3.68475 |
[BP] GO:0002682 | regulation of immune system process | ADORA1, ALOX15, APP, AXL, BCL2, CA2, CNR1, CNR2, CYP19A1, DUSP3, ESR1, HCAR2, HIF1A, HSPA1A, IDO1, MMP12, MMP2, PIK3CA, PIK3CB, PTPN1, SMAD3, SRC | 3.67518 |
[BP] GO:2000106 | regulation of leukocyte apoptotic process | AURKB, AXL, HCAR2, HIF1A, IDO1, PIK3CB | 3.65561 |
[BP] GO:0048660 | regulation of smooth muscle cell proliferation | AKR1B1, EGFR, HTR1B, MMP2, MMP9, PTGS2, TERT | 3.64962 |
[BP] GO:0055082 | cellular chemical homeostasis | APP, BCL2, CA2, CA7, ESR1, GPR35, HIF1A, HRH4, HTR2A, HTR2B, HTR2C, PIK3CA, PIK3CB, SMAD3 | 3.64602 |
[BP] GO:0001775 | cell activation | ALOX5, APP, AXL, BCL2, EGFR, FLT3, FUCA1, FUT7, GAA, HSPA1A, MGAM, MMP9, MPO, PIK3CA, PIK3CB, SMAD3, SRC | 3.62549 |
[BP] GO:1901701 | cellular response to oxygen-containing compound | AKR1B1, APEX1, APP, AXL, CYP1B1, DNMT1, EGFR, ESR1, IGF1R, INSR, MMP2, MMP9, PIK3CA, PTGS2, SRC | 3.62265 |
[BP] GO:0038083 | peptidyl-tyrosine autophosphorylation | EGFR, IGF1R, INSR, KDR, SRC | 3.62244 |
[BP] GO:0071417 | cellular response to organonitrogen compound | AKR1B1, APEX1, APP, DNMT1, EGFR, HTR1B, IGF1R, INSR, MMP2, PTGS2, SRC | 3.61619 |
[BP] GO:0043085 | positive regulation of catalytic activity | ADORA1, APP, AURKB, BCL2, CDC25B, EGFR, ESR1, FLT3, HIF1A, HSPA1A, HTR2A, HTR2B, INSR, PIK3CA, PIK3CB, PTPN1, SMAD3, SRC, TEK, TERT, XDH | 3.61493 |
[BP] GO:0007346 | regulation of mitotic cell cycle | APEX1, APP, AURKB, BCL2, CDC25B, CYP1A1, DUSP3, EGFR, HSPA1A, INSR, PIM1, SMAD3, TERT, TOP2A | 3.61134 |
[BP] GO:0030003 | cellular cation homeostasis | APP, BCL2, CA2, CA7, ESR1, GPR35, HIF1A, HRH4, HTR2A, HTR2B, HTR2C, PIK3CB, SMAD3 | 3.61134 |
[BP] GO:0019752 | carboxylic acid metabolic process | ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, DAO, FABP3, GLO1, HIF1A, IDO1, PIM1, PPARA, PTGS1, PTGS2, TYR | 3.60662 |
[BP] GO:0006082 | organic acid metabolic process | ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, DAO, FABP3, GLO1, HIF1A, IDO1, MPO, PIM1, PPARA, PTGS1, PTGS2, TYR | 3.60322 |
[BP] GO:0051246 | regulation of protein metabolic process | ADORA1, ALOX15, APP, BCL2, CDC25B, CSNK2A1, DNMT1, DUSP3, DYRK1A, EGFR, ESR1, FABP4, FLT3, GBA, HRH4, HSPA1A, HTR2A, HTR2B, HTR2C, IGF1R, INSR, KDR, MMP9, NUAK1, PIK3CA, PIK3CB, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH | 3.60219 |
[BP] GO:1904707 | positive regulation of vascular smooth muscle cell proliferation | HTR1B, MMP2, MMP9, TERT | 3.58254 |
[BP] GO:0031323 | regulation of cellular metabolic process | ACHE, ADORA1, ADORA3, ALOX15, APEX1, APP, AURKB, BCL2, CA9, CDC25B, CNR1, CSNK2A1, CYP1B1, DNMT1, DUSP3, DYRK1A, EGFR, ESR1, FABP3, FABP4, FLT3, GBA, GLO1, HIF1A, HRH3, HRH4, HSPA1A, HTR1A, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, IGF1R, INSR, KDR, MET, MMP12, MMP9, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, TOP2A, XDH | 3.56031 |
[BP] GO:0014062 | None | HRH3, HTR1A, HTR1B | 3.55282 |
[BP] GO:0010511 | None | HTR2A, HTR2B, HTR2C | 3.55282 |
[BP] GO:0050789 | regulation of biological process | ABCB1, ACHE, ADORA1, ADORA3, AKR1B1, ALOX15, APEX1, APP, AURKB, AXL, BACE1, BCL2, CA1, CA2, CA7, CA9, CDC25B, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DUSP3, DYRK1A, EGFR, ESR1, FABP3, FABP4, FLT3, GAA, GBA, GLO1, GPR35, HCAR2, HIF1A, HRH3, HRH4, HSPA1A, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IDO1, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, MPO, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, TOP2A, XDH | 3.53448 |
[BP] GO:0031667 | response to nutrient levels | ALPL, BCL2, CNR1, CYP1A1, EGFR, GBA, HSD11B2, MPO, PTGS2, SRC, TYR | 3.53362 |
[BP] GO:0006873 | cellular ion homeostasis | APP, BCL2, CA2, CA7, ESR1, GPR35, HIF1A, HRH4, HTR2A, HTR2B, HTR2C, PIK3CB, SMAD3 | 3.51257 |
[BP] GO:0051341 | None | CNR1, CNR2, EGFR, HIF1A, HTR2B, TERT | 3.51124 |
[BP] GO:0034599 | cellular response to oxidative stress | AKR1B1, APEX1, AXL, CYP1B1, EGFR, HSPA1A, MMP9, SRC | 3.49125 |
[BP] GO:0071495 | cellular response to endogenous stimulus | AKR1B1, APEX1, APP, DNMT1, EGFR, ESR1, FLT3, HTR1B, IGF1R, INSR, MMP2, PTGS2, SMAD3, SRC | 3.4579 |
[BP] GO:0031329 | regulation of cellular catabolic process | APEX1, BCL2, CNR1, GBA, HIF1A, HSPA1A, HTR2A, HTR2B, INSR, KDR, MET, PIK3CA, PIK3CB, PPARA, PTPN1 | 3.45273 |
[BP] GO:0051384 | response to glucocorticoid | ALPL, BCL2, EGFR, FLT3, GBA, HSD11B2, PTGS2 | 3.45273 |
[BP] GO:0008210 | estrogen metabolic process | CYP19A1, CYP1B1, HSD17B1, HSD17B2 | 3.44638 |
[BP] GO:1903409 | reactive oxygen species biosynthetic process | CYP1A1, CYP1A2, CYP1B1, MPO | 3.44638 |
[BP] GO:0046883 | regulation of hormone secretion | ADORA1, CNR1, CYP19A1, EGFR, HCAR2, HIF1A, HTR1A, HTR2A, HTR2C | 3.44638 |
[BP] GO:0043406 | positive regulation of MAP kinase activity | ADORA1, EGFR, FLT3, HTR2A, HTR2B, INSR, PIK3CB, PTPN1, SRC | 3.43445 |
[BP] GO:0071900 | regulation of protein serine/threonine kinase activity | ADORA1, DUSP3, EGFR, FLT3, GBA, HTR2A, HTR2B, IGF1R, INSR, PIK3CB, PTPN1, SRC | 3.4269 |
[BP] GO:0072507 | divalent inorganic cation homeostasis | APP, BCL2, EGFR, ESR1, GPR35, HRH4, HTR2A, HTR2B, HTR2C, PIK3CB, SMAD3 | 3.42334 |
[BP] GO:0045931 | positive regulation of mitotic cell cycle | APEX1, APP, CDC25B, CYP1A1, DUSP3, INSR, TERT | 3.36424 |
[BP] GO:0016042 | lipid catabolic process | ADORA1, AKR1B10, CYP19A1, CYP1A2, CYP1B1, FABP3, FABP4, FUCA1, GBA | 3.36399 |
[BP] GO:0050890 | None | ADORA1, APP, CNR1, EGFR, HIF1A, HRH3, HTR2A, INSR, PTGS2 | 3.33951 |
[BP] GO:0043393 | regulation of protein binding | APP, AURKB, BCL2, MET, MMP9, PPARA, SRC, TERT | 3.33629 |
[BP] GO:1901699 | cellular response to nitrogen compound | AKR1B1, APEX1, APP, DNMT1, EGFR, HTR1B, IGF1R, INSR, MMP2, PTGS2, SRC | 3.33592 |
[BP] GO:0040011 | locomotion | AXL, CNR2, CYP1B1, EGFR, FUT7, HIF1A, HTR2B, HTR6, KDR, MET, MMP1, MMP12, MMP9, PIK3CA, PIK3CB, SRC, TEK | 3.30803 |
[BP] GO:0071407 | cellular response to organic cyclic compound | ALPL, APEX1, APP, CYP1A1, CYP1B1, EGFR, ESR1, FLT3, PTGS2, SRC | 3.29841 |
[BP] GO:0071248 | cellular response to metal ion | ALOX15, CYP1A1, CYP1A2, EGFR, FABP4, MMP9, PTGS2 | 3.29841 |
[BP] GO:0048870 | cell motility | AXL, CNR2, CYP1B1, EGFR, FUT7, HIF1A, HTR2B, HTR6, KDR, MMP1, MMP12, MMP9, PIK3CA, PIK3CB, SRC, TEK | 3.29335 |
[BP] GO:0090087 | None | ACHE, ADORA1, APP, CA2, CNR1, EGFR, HCAR2, HIF1A, HTR2B, HTR2C, MMP12, PTGS2, PTPN1, SMAD3, SRC | 3.29188 |
[BP] GO:0008217 | None | ADORA1, CNR1, HSD11B2, PPARA, PTGS1, PTGS2, SMAD3 | 3.28328 |
[BP] GO:0050794 | regulation of cellular process | ACHE, ADORA1, ADORA3, AKR1B1, ALOX15, APEX1, APP, AURKB, AXL, BACE1, BCL2, CA1, CA2, CA7, CA9, CDC25B, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DNMT1, DUSP3, DYRK1A, EGFR, ESR1, FABP3, FABP4, FLT3, GBA, GLO1, GPR35, HCAR2, HIF1A, HRH3, HRH4, HSPA1A, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IDO1, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, MPO, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, TOP2A, XDH | 3.2826 |
[BP] GO:2001234 | negative regulation of apoptotic signaling pathway | BCL2, HIF1A, HSPA1A, MMP9, PTGS2, PTPN1, SRC, TERT | 3.2636 |
[BP] GO:0051171 | regulation of nitrogen compound metabolic process | ADORA1, ADORA3, ALOX15, APEX1, APP, AURKB, BCL2, CA9, CDC25B, CSNK2A1, CYP1B1, DNMT1, DUSP3, DYRK1A, EGFR, ESR1, FABP3, FABP4, FLT3, GBA, GLO1, HIF1A, HRH3, HRH4, HSPA1A, HTR1A, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, IGF1R, INSR, KDR, MET, MMP12, MMP9, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, TOP2A, XDH | 3.24859 |
[BP] GO:0017144 | drug metabolic process | ACHE, AKR1B1, AKR1B10, CBR1, CYP1A1, CYP1A2, CYP1B1, DAO, EGFR, HSPA1A, IDO1, MPO | 3.24552 |
[BP] GO:0002009 | morphogenesis of an epithelium | BCL2, CA2, CA9, EGFR, ESR1, HIF1A, MET, SMAD3, SRC | 3.23912 |
[BP] GO:0035690 | cellular response to drug | AKR1B1, APEX1, AXL, CYP1B1, EGFR, HTR1B, KDR, PTGS2, SRC | 3.23912 |
[BP] GO:0051828 | entry into other organism involved in symbiotic interaction | AXL, EGFR, HSPA1A, HTR2A, MET, SRC | 3.21929 |
[BP] GO:0051806 | entry into cell of other organism involved in symbiotic interaction | AXL, EGFR, HSPA1A, HTR2A, MET, SRC | 3.21929 |
[BP] GO:0030260 | entry into host cell | AXL, EGFR, HSPA1A, HTR2A, MET, SRC | 3.21929 |
[BP] GO:0044409 | entry into host | AXL, EGFR, HSPA1A, HTR2A, MET, SRC | 3.21929 |
[BP] GO:0072593 | reactive oxygen species metabolic process | BCL2, CYP1A1, CYP1A2, CYP1B1, EGFR, MPO | 3.19593 |
[BP] GO:0001952 | regulation of cell-matrix adhesion | BCL2, KDR, PIK3CB, SMAD3, SRC, TEK | 3.1754 |
[BP] GO:0048015 | phosphatidylinositol-mediated signaling | HTR2A, HTR2B, IGF1R, PIK3CA, PIK3CB | 3.14712 |
[BP] GO:2001242 | regulation of intrinsic apoptotic signaling pathway | BCL2, HIF1A, HSPA1A, MMP9, PTGS2, PTPN1, SRC | 3.14414 |
[BP] GO:0090066 | None | ADORA1, ALOX15, EGFR, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2 | 3.14313 |
[BP] GO:0055065 | metal ion homeostasis | APP, BCL2, EGFR, ESR1, GPR35, HIF1A, HRH4, HTR2A, HTR2B, HTR2C, PIK3CB, SMAD3 | 3.12831 |
[BP] GO:0045787 | positive regulation of cell cycle | APEX1, APP, AURKB, CDC25B, CYP1A1, DUSP3, EGFR, INSR, SRC, TERT | 3.1253 |
[BP] GO:0009968 | negative regulation of signal transduction | BCL2, DUSP3, DYRK1A, EGFR, ESR1, GBA, HIF1A, HSPA1A, IGF1R, MET, MMP12, MMP9, PTGS2, PTPN1, SMAD3, SRC, TERT, XDH | 3.10954 |
[BP] GO:0033674 | positive regulation of kinase activity | ADORA1, CDC25B, EGFR, FLT3, HTR2A, HTR2B, INSR, PIK3CA, PIK3CB, PTPN1, SRC, TEK | 3.10954 |
[BP] GO:0042743 | hydrogen peroxide metabolic process | CYP1A1, CYP1A2, EGFR, MPO | 3.10667 |
[BP] GO:2001225 | regulation of chloride transport | ABCB1, CA2, CA7 | 3.10518 |
[BP] GO:0097267 | omega-hydroxylase P450 pathway | CYP1A1, CYP1A2, CYP1B1 | 3.10518 |
[BP] GO:0042542 | response to hydrogen peroxide | AKR1B1, APEX1, AXL, BCL2, CYP1B1, SRC | 3.07724 |
[BP] GO:0080135 | regulation of cellular response to stress | APP, DUSP3, DYRK1A, EGFR, HIF1A, HSPA1A, IGF1R, MET, NUAK1, PTGS2, PTPN1, TERT, XDH | 3.07458 |
[BP] GO:0099536 | None | CNR1, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7 | 3.07146 |
[BP] GO:0099537 | None | CNR1, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7 | 3.07146 |
[BP] GO:0046889 | None | FABP3, HTR2A, HTR2B, HTR2C, PTGS2 | 3.06785 |
[BP] GO:0048017 | inositol lipid-mediated signaling | HTR2A, HTR2B, IGF1R, PIK3CA, PIK3CB | 3.06785 |
[BP] GO:0006874 | cellular calcium ion homeostasis | APP, BCL2, ESR1, GPR35, HRH4, HTR2A, HTR2B, HTR2C, PIK3CB, SMAD3 | 3.04515 |
[BP] GO:0007154 | None | ADORA1, AXL, BCL2, CNR1, GBA, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7, PTGS2, TEK | 2.99719 |
[BP] GO:1900542 | None | HIF1A, HRH3, HRH4, HTR1B, HTR1E, HTR2A, INSR, PPARA | 2.98419 |
[BP] GO:0019371 | None | CBR1, PTGS1, PTGS2 | 2.98419 |
[BP] GO:1902893 | None | HIF1A, PPARA, SMAD3, TERT | 2.95801 |
[BP] GO:0010863 | positive regulation of phospholipase C activity | EGFR, ESR1, HTR2A, HTR2B | 2.95801 |
[BP] GO:0030155 | regulation of cell adhesion | ALOX15, BCL2, CYP1B1, DUSP3, IDO1, KDR, NUAK1, PIK3CA, PIK3CB, PPARA, SMAD3, SRC, TEK | 2.94914 |
[BP] GO:0045913 | None | HIF1A, HTR2A, INSR, PPARA, SRC | 2.94815 |
[BP] GO:0055074 | calcium ion homeostasis | APP, BCL2, ESR1, GPR35, HRH4, HTR2A, HTR2B, HTR2C, PIK3CB, SMAD3 | 2.94022 |
[BP] GO:0071241 | cellular response to inorganic substance | ALOX15, CYP1A1, CYP1A2, EGFR, FABP4, MMP9, PTGS2 | 2.94022 |
[BP] GO:0042180 | None | AKR1B1, AKR1B10, CYP19A1, GLO1, IDO1 | 2.92182 |
[BP] GO:0006875 | cellular metal ion homeostasis | APP, BCL2, ESR1, GPR35, HIF1A, HRH4, HTR2A, HTR2B, HTR2C, PIK3CB, SMAD3 | 2.90541 |
[BP] GO:0006140 | None | HIF1A, HRH3, HRH4, HTR1B, HTR1E, HTR2A, INSR, PPARA | 2.90504 |
[BP] GO:0072503 | cellular divalent inorganic cation homeostasis | APP, BCL2, ESR1, GPR35, HRH4, HTR2A, HTR2B, HTR2C, PIK3CB, SMAD3 | 2.89889 |
[BP] GO:0048732 | gland development | BCL2, CSNK2A1, CYP19A1, EGFR, INSR, PIK3CA, SMAD3, TYR | 2.89446 |
[BP] GO:0048871 | multicellular organismal homeostasis | ADORA1, AKR1B1, GBA, HTR2A, MET, PIK3CA | 2.88405 |
[BP] GO:0007208 | None | HTR2A, HTR2C | 2.88251 |
[BP] GO:0045759 | None | CNR1, CNR2, GPR35 | 2.88173 |
[BP] GO:1900543 | None | HRH3, HRH4, HTR1B, HTR1E, PPARA | 2.87387 |
[BP] GO:0051347 | positive regulation of transferase activity | ADORA1, AURKB, CDC25B, EGFR, FLT3, HTR2A, HTR2B, INSR, PIK3CA, PIK3CB, PTPN1, SRC, TEK | 2.8616 |
[BP] GO:0001101 | response to acid chemical | AKR1B1, DNMT1, EGFR, FABP3, HSD17B2, KDR, MMP2, PTGS2, SRC | 2.84879 |
[BP] GO:0045980 | None | HRH3, HRH4, HTR1B, HTR1E, PPARA | 2.84877 |
[BP] GO:0048010 | vascular endothelial growth factor receptor signaling pathway | AXL, KDR, PIK3CA, PIK3CB, SRC | 2.84877 |
[BP] GO:0050806 | positive regulation of synaptic transmission | ADORA1, APP, CA2, CA7, EGFR, PTGS2 | 2.83473 |
[BP] GO:0051051 | negative regulation of transport | ADORA1, APP, BCL2, CNR1, GPR35, HRH3, HSPA1A, HTR1B, HTR2A, MMP9, PTGS2 | 2.83418 |
[BP] GO:1900274 | regulation of phospholipase C activity | EGFR, ESR1, HTR2A, HTR2B | 2.83218 |
[BP] GO:0097164 | None | ACHE, AKR1B1, AKR1B10, CSNK2A1, DAO, GBA, HTR1A | 2.80514 |
[BP] GO:0051094 | positive regulation of developmental process | APP, AXL, BCL2, CA2, CNR1, CYP1B1, HIF1A, HTR2A, HTR2C, IDO1, INSR, KDR, PIM1, PTGS2, SMAD3, SRC, TEK, TERT | 2.79258 |
[BP] GO:0046456 | icosanoid biosynthetic process | ALOX15, ALOX5, PTGS1, PTGS2 | 2.78852 |
[BP] GO:0006703 | estrogen biosynthetic process | CYP19A1, HSD17B1, HSD17B2 | 2.78384 |
[BP] GO:0003006 | developmental process involved in reproduction | ALPL, AXL, BCL2, CDC25B, CYP19A1, EGFR, ESR1, HIF1A, HSD17B2, INSR, PTGS2, SRC | 2.77727 |
[BP] GO:0001505 | regulation of neurotransmitter levels | ACHE, CYP1B1, EGFR, HRH3, HTR1A, INSR, PTGS2, SMAD3 | 2.75684 |
[BP] GO:0002793 | None | ACHE, ADORA1, EGFR, HCAR2, HIF1A, HTR2B, MMP12, SRC | 2.75684 |
[BP] GO:1901215 | negative regulation of neuron death | AXL, BCL2, GBA, HIF1A, PIK3CA, PPARA, TERT | 2.7535 |
[BP] GO:0051952 | None | ADORA1, CNR1, HRH3, HTR1B, HTR2A | 2.74969 |
[BP] GO:0006694 | steroid biosynthetic process | AKR1B1, CYP19A1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 | 2.74969 |
[BP] GO:0001525 | angiogenesis | CYP1B1, HIF1A, KDR, MMP2, PIK3CA, PIK3CB, PTGS2, TEK | 2.74909 |
[BP] GO:0015711 | organic anion transport | ABCB1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, FABP3, PPARA | 2.74899 |
[BP] GO:0009605 | response to external stimulus | ADORA1, ALPL, AXL, BCL2, CNR1, CNR2, CYP1A1, CYP1A2, EGFR, GBA, HSD11B2, HTR2A, IDO1, MMP12, MPO, PTGS2, SMAD3, SRC, TYR | 2.7467 |
[BP] GO:0043065 | positive regulation of apoptotic process | BCL2, CNR1, CYP1B1, HCAR2, IDO1, MMP9, PIK3CB, PTGS2, SMAD3, SRC, TOP2A, XDH | 2.73138 |
[BP] GO:0010810 | regulation of cell-substrate adhesion | ALOX15, BCL2, KDR, PIK3CB, SMAD3, SRC, TEK | 2.73138 |
[BP] GO:0044248 | cellular catabolic process | ACHE, AKR1B10, AURKB, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DAO, FABP3, FABP4, FUCA1, GAA, GBA, HSPA1A, IDO1, MGAM, MPO, PIK3CB, SRC, XDH | 2.71887 |
[BP] GO:0045860 | positive regulation of protein kinase activity | ADORA1, CDC25B, EGFR, FLT3, HTR2A, HTR2B, INSR, PIK3CA, PIK3CB, PTPN1, SRC | 2.71362 |
[BP] GO:1904705 | regulation of vascular smooth muscle cell proliferation | HTR1B, MMP2, MMP9, TERT | 2.71264 |
[BP] GO:1904951 | positive regulation of establishment of protein localization | ACHE, APP, BCL2, EGFR, HCAR2, HIF1A, HTR2B, MMP12, PTGS2, SMAD3, SRC | 2.70808 |
[BP] GO:0018958 | None | AKR1B1, BCL2, DAO, HTR1A, TYR | 2.70612 |
[BP] GO:0060065 | uterus development | CYP19A1, ESR1, SRC | 2.69997 |
[BP] GO:0051967 | None | ADORA1, HTR1B, HTR2A | 2.69997 |
[BP] GO:0043068 | positive regulation of programmed cell death | BCL2, CNR1, CYP1B1, HCAR2, IDO1, MMP9, PIK3CB, PTGS2, SMAD3, SRC, TOP2A, XDH | 2.69915 |
[BP] GO:0051726 | regulation of cell cycle | APEX1, APP, AURKB, BCL2, CDC25B, CSNK2A1, CYP1A1, DUSP3, EGFR, HSPA1A, INSR, PIM1, PTGS2, SMAD3, SRC, TERT, TOP2A | 2.69704 |
[BP] GO:1900182 | positive regulation of protein localization to nucleus | APP, EGFR, PTGS2, SMAD3, SRC, TERT | 2.68925 |
[BP] GO:0044057 | None | ADORA1, ADORA3, EGFR, GAA, GBA, GPR35, HCAR2, HTR2A, HTR2C, PTGS2, SMAD3 | 2.68493 |
[BP] GO:0051098 | regulation of binding | APP, AURKB, BCL2, MET, MMP9, PPARA, SMAD3, SRC, TERT | 2.67035 |
[BP] GO:1901575 | None | ACHE, ADORA1, AKR1B10, AURKB, BACE1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DAO, FABP3, FABP4, FUCA1, FUT7, GAA, GBA, HSPA1A, IDO1, MGAM, XDH | 2.65988 |
[BP] GO:1904407 | positive regulation of nitric oxide metabolic process | EGFR, INSR, PTGS2, SMAD3 | 2.63843 |
[BP] GO:0045429 | positive regulation of nitric oxide biosynthetic process | EGFR, INSR, PTGS2, SMAD3 | 2.63843 |
[BP] GO:0032963 | collagen metabolic process | HIF1A, MMP1, MMP12, MMP2, MMP9 | 2.63843 |
[BP] GO:0006954 | inflammatory response | ADORA1, ADORA3, ALOX15, AXL, CNR2, HRH4, PIK3CA, PIK3CB, PTGS1, PTGS2 | 2.62406 |
[BP] GO:0044070 | regulation of anion transport | ABCB1, ADORA1, CA2, CA7, HRH3 | 2.61582 |
[BP] GO:0033273 | response to vitamin | ALPL, CYP1A1, EGFR, PTGS2, TYR | 2.61582 |
[BP] GO:0071902 | positive regulation of protein serine/threonine kinase activity | ADORA1, EGFR, FLT3, HTR2A, HTR2B, INSR, PIK3CB, PTPN1, SRC | 2.60105 |
[BP] GO:0044283 | None | AKR1B1, ALOX15, ALOX5, CYP19A1, CYP1A1, GBA, IDO1, MPO, PTGS1, PTGS2 | 2.59481 |
[BP] GO:0001816 | cytokine production | APP, FABP4, HIF1A, IDO1, PTGS2 | 2.59354 |
[BP] GO:0009653 | anatomical structure morphogenesis | APP, AXL, BCL2, CA2, CA9, CYP1B1, EGFR, ESR1, GAA, GBA, HIF1A, HTR2B, INSR, MET, MMP2, SMAD3, SRC, TEK | 2.57543 |
[BP] GO:1901989 | None | APEX1, APP, CDC25B, CYP1A1, TERT | 2.57056 |
[BP] GO:0048729 | tissue morphogenesis | BCL2, CA2, CA9, EGFR, ESR1, HIF1A, MET, SMAD3, SRC | 2.56813 |
[BP] GO:0001961 | None | AXL, HIF1A, HSPA1A, MMP12 | 2.56658 |
[BP] GO:0009896 | positive regulation of catabolic process | CSNK2A1, GBA, HIF1A, HSPA1A, HTR2A, INSR, KDR, PIK3CB, PPARA, PTPN1 | 2.55156 |
[BP] GO:0010595 | positive regulation of endothelial cell migration | HIF1A, KDR, MET, PTGS2, TEK | 2.54989 |
[BP] GO:2000811 | negative regulation of anoikis | BCL2, PIK3CA, SRC | 2.54243 |
[BP] GO:0030540 | female genitalia development | AXL, CYP19A1, ESR1 | 2.54243 |
[BP] GO:0070920 | None | EGFR, ESR1, TERT | 2.54243 |
[BP] GO:0048546 | None | BCL2, EGFR, HIF1A | 2.54243 |
[BP] GO:0019372 | lipoxygenase pathway | ALOX15, ALOX5, PTGS2 | 2.54243 |
[BP] GO:0043434 | None | APEX1, FABP3, HSD11B2, INSR, PPARA, PTGS2, SRC, TEK | 2.53543 |
[BP] GO:0044259 | multicellular organismal macromolecule metabolic process | HIF1A, MMP1, MMP12, MMP2, MMP9 | 2.53247 |
[BP] GO:0032103 | positive regulation of response to external stimulus | CNR1, EGFR, FABP4, IDO1, KDR, MET, PTGS2, SMAD3 | 2.52647 |
[BP] GO:0002791 | None | ACHE, ADORA1, CNR1, EGFR, HCAR2, HIF1A, HTR2B, HTR2C, MMP12, SRC | 2.50495 |
[BP] GO:0000023 | None | GAA, MGAM | 2.48 |
[BP] GO:0032849 | positive regulation of cellular pH reduction | CA2, CA7 | 2.48 |
[BP] GO:0032845 | None | ADORA1, BCL2, HTR2A, HTR2B, HTR2C, SRC | 2.47718 |
[BP] GO:2000379 | positive regulation of reactive oxygen species metabolic process | EGFR, INSR, PTGS2, SMAD3, XDH | 2.45061 |
[BP] GO:2000107 | negative regulation of leukocyte apoptotic process | AURKB, AXL, HIF1A, IDO1 | 2.43744 |
[BP] GO:0050433 | None | CNR1, HRH3, HTR1B, HTR2A | 2.43744 |
[BP] GO:0060760 | None | AXL, HIF1A, HSPA1A, MMP12 | 2.43744 |
[BP] GO:0018193 | peptidyl-amino acid modification | AURKB, AXL, BCL2, CSNK2A1, DYRK1A, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK, TOP2A | 2.43228 |
[BP] GO:0010942 | positive regulation of cell death | BCL2, CNR1, CYP1B1, HCAR2, IDO1, MMP9, PIK3CB, PTGS2, SMAD3, SRC, TOP2A, XDH | 2.43017 |
[BP] GO:0035239 | tube morphogenesis | BCL2, EGFR, ESR1, HIF1A, MET, SMAD3, SRC | 2.41796 |
[BP] GO:0010632 | regulation of epithelial cell migration | HIF1A, KDR, MET, MMP9, PTGS2, SRC, TEK | 2.41796 |
[BP] GO:0051128 | regulation of cellular component organization | ALOX15, APP, AURKB, AXL, BCL2, CNR1, CSNK2A1, DNMT1, EGFR, ESR1, GBA, HIF1A, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP9, PIK3CB, PTPN1, SMAD3, SRC, TEK, TOP2A | 2.40975 |
[BP] GO:0007268 | None | HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7 | 2.40975 |
[BP] GO:0098916 | None | HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7 | 2.40975 |
[BP] GO:0030815 | None | HRH3, HRH4, HTR1B, HTR1E | 2.40975 |
[BP] GO:0006939 | None | HTR1D, HTR2A, HTR2B, HTR7 | 2.40975 |
[BP] GO:0051000 | None | HIF1A, HTR2B, TERT | 2.40975 |
[BP] GO:0045821 | None | HIF1A, HTR2A, INSR | 2.40975 |
[BP] GO:0043086 | negative regulation of catalytic activity | APP, CNR1, CNR2, CSNK2A1, DUSP3, FABP4, GBA, HRH3, HRH4, IGF1R, MMP9, PTGS2, PTPN1, SRC | 2.40597 |
[BP] GO:0009266 | None | ADORA1, HSPA1A, HTR1B, HTR2A, HTR2B, PTGS2 | 2.39686 |
[BP] GO:0010518 | positive regulation of phospholipase activity | EGFR, ESR1, HTR2A, HTR2B | 2.38052 |
[BP] GO:2001233 | regulation of apoptotic signaling pathway | BCL2, HIF1A, HSPA1A, MMP9, PTGS2, PTPN1, SMAD3, SRC, TERT | 2.37444 |
[BP] GO:0006952 | defense response | ADORA1, ADORA3, ALOX15, APP, AXL, BCL2, CNR2, HRH4, HTR1A, HTR2C, MPO, PIK3CA, PIK3CB, PTGS1, PTGS2, SRC | 2.36798 |
[BP] GO:0051047 | None | ACHE, ADORA1, CYP19A1, EGFR, HCAR2, HIF1A, HTR2B, MMP12, SRC | 2.36762 |
[BP] GO:0006928 | movement of cell or subcellular component | APP, AXL, CNR2, CYP1B1, EGFR, FUT7, HIF1A, HTR2B, HTR6, KDR, MMP1, MMP12, MMP9, PIK3CA, PIK3CB, PTGS2, SRC, TEK | 2.36167 |
[BP] GO:0051704 | multi-organism process | APP, AXL, BCL2, CYP1A1, DYRK1A, EGFR, HSD11B2, HSPA1A, HTR2A, IDO1, INSR, KDR, MET, MMP1, MMP12, MPO, SMAD3, SRC | 2.35552 |
[BP] GO:0030800 | None | HRH3, HRH4, HTR1B, HTR1E | 2.35257 |
[BP] GO:0051900 | regulation of mitochondrial depolarization | BCL2, KDR, SRC | 2.35033 |
[BP] GO:0051197 | None | HIF1A, HTR2A, INSR | 2.35033 |
[BP] GO:0045766 | positive regulation of angiogenesis | CYP1B1, HIF1A, KDR, PTGS2, TEK, TERT | 2.34563 |
[BP] GO:0033554 | cellular response to stress | AKR1B1, ALOX15, APEX1, AXL, BCL2, CA2, CA9, CYP1B1, EGFR, GBA, HIF1A, HSPA1A, MMP9, NUAK1, PTGS2, PTPN1, SRC, TERT, TOP2A | 2.32423 |
[BP] GO:0051222 | positive regulation of protein transport | ACHE, APP, EGFR, HCAR2, HIF1A, HTR2B, MMP12, PTGS2, SMAD3, SRC | 2.32289 |
[BP] GO:0035556 | intracellular signal transduction | AKR1B1, AXL, BCL2, CYP1B1, DNMT1, EGFR, HTR2A, HTR2B, HTR5A, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIK3CB, PTPN1, SRC, TEK | 2.32227 |
[BP] GO:1903428 | positive regulation of reactive oxygen species biosynthetic process | EGFR, INSR, PTGS2, SMAD3 | 2.29458 |
[BP] GO:0050994 | None | ADORA1, CNR1, HCAR2, PPARA | 2.29458 |
[BP] GO:0032880 | regulation of protein localization | ACHE, APP, BCL2, CNR1, CSNK2A1, EGFR, HCAR2, HIF1A, HTR2B, MMP12, PTGS2, PTPN1, SMAD3, SRC, TERT | 2.29458 |
[BP] GO:0009891 | positive regulation of biosynthetic process | APP, AURKB, EGFR, ESR1, FABP3, GBA, HIF1A, HTR2A, HTR2B, HTR2C, IGF1R, INSR, KDR, MET, MMP12, PPARA, PTGS2, SMAD3, SRC, TERT, TOP2A | 2.29458 |
[BP] GO:0033138 | positive regulation of peptidyl-serine phosphorylation | APP, BCL2, EGFR, PIK3CA, PTGS2 | 2.29057 |
[BP] GO:0010506 | regulation of autophagy | BCL2, GBA, HIF1A, HTR2B, KDR, MET, PIK3CA, PIK3CB | 2.28689 |
[BP] GO:0001819 | positive regulation of cytokine production | CYP1B1, HIF1A, HSPA1A, HTR2B, IDO1, MMP12, PTGS2, SMAD3, SRC | 2.27636 |
[BP] GO:0031331 | positive regulation of cellular catabolic process | GBA, HIF1A, HSPA1A, HTR2A, INSR, KDR, PIK3CB, PPARA, PTPN1 | 2.27636 |
[BP] GO:0098900 | None | CNR1, CNR2, GBA, GPR35 | 2.26903 |
[BP] GO:0051172 | None | APEX1, APP, AURKB, CSNK2A1, DNMT1, DUSP3, DYRK1A, EGFR, ESR1, FABP4, GBA, HRH3, HRH4, HSPA1A, HTR1B, HTR1E, IGF1R, MMP12, MMP9, PPARA, PTGS2, PTPN1, SMAD3, SRC, TERT, XDH | 2.26468 |
[BP] GO:0050730 | None | ADORA1, APP, EGFR, FLT3, HTR2A, PTPN1, SRC | 2.25902 |
[BP] GO:0045936 | None | DUSP3, FABP4, GBA, HRH3, HRH4, HTR1B, HTR1E, IGF1R, PPARA, PTPN1, XDH | 2.24846 |
[BP] GO:0043207 | response to external biotic stimulus | ALPL, AXL, BCL2, CNR1, CNR2, CYP1A1, CYP1A2, IDO1, MMP12, MPO, PTGS2, SMAD3, SRC | 2.24584 |
[BP] GO:0010563 | None | DUSP3, FABP4, GBA, HRH3, HRH4, HTR1B, HTR1E, IGF1R, PPARA, PTPN1, XDH | 2.24584 |
[BP] GO:1901617 | organic hydroxy compound biosynthetic process | AKR1B1, ALOX15, CYP19A1, DAO, GBA, TYR | 2.24584 |
[BP] GO:0022900 | electron transport chain | AKR1B1, CYP19A1, CYP1A2, IDO1, NQO2, XDH | 2.24584 |
[BP] GO:0051893 | regulation of focal adhesion assembly | KDR, SMAD3, SRC, TEK | 2.24584 |
[BP] GO:0033555 | multicellular organismal response to stress | BCL2, HTR1A, HTR2C, IDO1 | 2.24584 |
[BP] GO:0090109 | regulation of cell-substrate junction assembly | KDR, SMAD3, SRC, TEK | 2.24584 |
[BP] GO:0042391 | None | ADORA1, APP, BCL2, CNR1, CNR2, GBA, GPR35, KDR, SRC | 2.24557 |
[BP] GO:0071498 | cellular response to fluid shear stress | CA2, PTGS2, SRC | 2.24217 |
[BP] GO:0032094 | None | CYP1A1, HSD11B2, MPO | 2.24217 |
[BP] GO:0019373 | epoxygenase P450 pathway | CYP1A1, CYP1A2, CYP1B1 | 2.24217 |
[BP] GO:0098908 | None | GBA, GPR35 | 2.24217 |
[BP] GO:0033031 | positive regulation of neutrophil apoptotic process | HCAR2, PIK3CB | 2.24217 |
[BP] GO:0038171 | None | CNR1, CNR2 | 2.24217 |
[BP] GO:0014063 | None | HRH3, HTR1B | 2.24217 |
[BP] GO:0018894 | dibenzo-p-dioxin metabolic process | CYP1A1, CYP1A2 | 2.24217 |
[BP] GO:0014827 | None | HTR1D, HTR2B | 2.24217 |
[BP] GO:0008285 | negative regulation of cell proliferation | ADORA1, ADORA3, APP, BCL2, CYP1B1, FABP3, HSPA1A, IDO1, PTGS2, SMAD3, TERT, XDH | 2.23373 |
[BP] GO:0050714 | None | ACHE, EGFR, HCAR2, HIF1A, HTR2B, MMP12, SRC | 2.23243 |
[BP] GO:0007611 | None | APP, CNR1, EGFR, HIF1A, HTR2A, INSR, PTGS2 | 2.23243 |
[BP] GO:0046486 | glycerolipid metabolic process | ACHE, ALOX15, CSNK2A1, EGFR, FABP3, FABP4, MET, PIK3CA, PIK3CB | 2.22655 |
[BP] GO:0008150 | biological_process | ABCB1, ACHE, ADORA1, ADORA3, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, APEX1, APP, AURKB, AXL, BACE1, BCL2, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CBR1, CDC25B, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DAO, DNMT1, DUSP3, DYRK1A, EGFR, ESR1, FABP3, FABP4, FLT3, FUCA1, FUT7, GAA, GBA, GLO1, GPR35, HCAR2, HIF1A, HRH3, HRH4, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IDO1, IGF1R, INSR, KDR, MET, MGAM, MMP1, MMP12, MMP2, MMP9, MPO, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, TOP2A, TYR, XDH | 2.22337 |
[BP] GO:0071456 | cellular response to hypoxia | BCL2, HIF1A, PTGS2, SRC, TERT | 2.2177 |
[BP] GO:0002683 | negative regulation of immune system process | ADORA1, ALOX15, AXL, CNR1, CNR2, CYP19A1, DUSP3, IDO1, MMP12 | 2.21294 |
[BP] GO:0046686 | response to cadmium ion | CYP1A2, EGFR, MMP9, TERT | 2.20246 |
[BP] GO:1902895 | None | HIF1A, SMAD3, TERT | 2.19727 |
[BP] GO:0051194 | None | HIF1A, HTR2A, INSR | 2.19727 |
[BP] GO:0050995 | None | ADORA1, CNR1, HCAR2 | 2.19727 |
[BP] GO:0048534 | hematopoietic or lymphoid organ development | BCL2, FLT3, HIF1A, KDR, TEK, TYR | 2.1963 |
[BP] GO:0070201 | None | ACHE, APP, BCL2, CNR1, EGFR, HCAR2, HIF1A, HTR2B, MMP12, PTGS2, PTPN1, SMAD3, SRC | 2.18804 |
[BP] GO:0044236 | multicellular organism metabolic process | HIF1A, MMP1, MMP12, MMP2, MMP9 | 2.18697 |
[BP] GO:1903391 | regulation of adherens junction organization | KDR, SMAD3, SRC, TEK | 2.17977 |
[BP] GO:0045428 | regulation of nitric oxide biosynthetic process | EGFR, INSR, PTGS2, SMAD3 | 2.17977 |
[BP] GO:0006721 | terpenoid metabolic process | AKR1B10, CYP1A1, CYP1A2, CYP1B1, EGFR | 2.17024 |
[BP] GO:0051953 | None | ADORA1, CNR1, HRH3 | 2.14535 |
[BP] GO:2000209 | regulation of anoikis | BCL2, PIK3CA, SRC | 2.14535 |
[BP] GO:0009404 | toxin metabolic process | CYP1A1, CYP1A2, CYP1B1 | 2.14535 |
[BP] GO:0031349 | positive regulation of defense response | CNR1, EGFR, FABP4, HSPA1A, IDO1, MMP12, MMP2, PTGS2, SRC | 2.13138 |
[BP] GO:0010517 | regulation of phospholipase activity | EGFR, ESR1, HTR2A, HTR2B | 2.12624 |
[BP] GO:0001817 | regulation of cytokine production | AXL, CYP1B1, GBA, HIF1A, HSPA1A, HTR2B, IDO1, MMP12, PTGS2, SMAD3, SRC | 2.12354 |
[BP] GO:0044242 | None | AKR1B10, CYP1B1, FABP3, FABP4, FUCA1, GBA | 2.12259 |
[BP] GO:0050678 | None | EGFR, HIF1A, HTR2B, KDR, MMP12, SMAD3, TEK, XDH | 2.11631 |
[BP] GO:0036294 | cellular response to decreased oxygen levels | BCL2, HIF1A, PTGS2, SRC, TERT | 2.10278 |
[BP] GO:0009607 | response to biotic stimulus | ALPL, AXL, BCL2, CNR1, CNR2, CYP1A1, CYP1A2, IDO1, MMP12, MPO, PTGS2, SMAD3, SRC | 2.10234 |
[BP] GO:0050679 | None | EGFR, HIF1A, HTR2B, KDR, MMP12, TEK | 2.09948 |
[BP] GO:1904018 | positive regulation of vasculature development | CYP1B1, HIF1A, KDR, PTGS2, TEK, TERT | 2.09948 |
[BP] GO:0051894 | None | KDR, SMAD3, TEK | 2.09837 |
[BP] GO:0007202 | None | EGFR, HTR2A, HTR2B | 2.09837 |
[BP] GO:0032098 | None | HTR2C, HTR4, PPARA | 2.09837 |
[BP] GO:0007267 | None | ADORA1, CNR1, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7, TEK | 2.08325 |
[BP] GO:0070301 | cellular response to hydrogen peroxide | AKR1B1, APEX1, AXL, CYP1B1 | 2.07947 |
[BP] GO:1901654 | None | AKR1B1, CA9, CSNK2A1, EGFR, GBA, SRC | 2.06425 |
[BP] GO:0006805 | xenobiotic metabolic process | CYP1A1, CYP1A2, CYP1B1, NQO2, PTGS1 | 2.05735 |
[BP] GO:0050729 | positive regulation of inflammatory response | CNR1, EGFR, FABP4, IDO1, PTGS2 | 2.05735 |
[BP] GO:0060193 | positive regulation of lipase activity | EGFR, ESR1, HTR2A, HTR2B | 2.05696 |
[BP] GO:0071502 | None | HTR1B, HTR2B | 2.05696 |
[BP] GO:0014050 | None | ADORA1, HRH3 | 2.05696 |
[BP] GO:0032770 | None | HIF1A, HTR2B, TERT | 2.05212 |
[BP] GO:0046466 | None | CYP1B1, FUCA1, GBA | 2.00421 |
[BP] GO:1903393 | None | KDR, SMAD3, TEK | 2.00421 |
[CC] GO:0005886 | plasma membrane | ABCB1, ACHE, ADORA1, ADORA3, ALOX15, ALPL, APP, AXL, BACE1, CA12, CA14, CA2, CA4, CA9, CNR1, CNR2, CSNK2A1, EGFR, ESR1, FLT3, GAA, GLO1, GPR35, HCAR2, HRH3, HRH4, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, MGAM, MMP2, PIK3CA, PIK3CB, PIM1, PTPN1, SMAD3, SRC, TEK, TERT | 8.07424 |
[CC] GO:0031226 | intrinsic component of plasma membrane | ADORA1, ADORA3, APP, AXL, BACE1, CA4, CNR1, CNR2, FLT3, GPR35, HRH3, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, TEK | 6.7348 |
[CC] GO:0005887 | integral component of plasma membrane | ADORA1, ADORA3, APP, AXL, BACE1, CNR1, CNR2, FLT3, GPR35, HRH3, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, TEK | 6.45804 |
[CC] GO:0044459 | plasma membrane part | ABCB1, ADORA1, ADORA3, ALOX15, APP, AXL, BACE1, CA2, CA4, CA9, CNR1, CNR2, DUSP3, EGFR, FLT3, GPR35, HRH3, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, MGAM, PTGS2, SRC, TEK | 6.28654 |
[CC] GO:0016020 | membrane | ABCB1, ACHE, ADORA1, ADORA3, ALOX15, ALOX5, ALPL, APP, AXL, BACE1, BCL2, CA12, CA14, CA2, CA4, CA9, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DAO, EGFR, ESR1, FLT3, FUT7, GAA, GBA, GLO1, GPR35, HCAR2, HRH3, HRH4, HSD11B1, HSD11B2, HSD17B2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, MGAM, MMP2, PIK3CA, PIK3CB, PIM1, PTGS1, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, TYR | 6.14727 |
[CC] GO:0044425 | membrane part | ABCB1, ACHE, ADORA1, ADORA3, ALOX15, ALPL, APP, AXL, BACE1, BCL2, CA12, CA14, CA2, CA4, CA9, CNR1, CNR2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EGFR, ESR1, FLT3, FUT7, GPR35, HCAR2, HRH3, HRH4, HSD11B1, HSD11B2, HSD17B2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, MGAM, PIK3CA, PIK3CB, PTGS1, PTGS2, PTPN1, SRC, TEK, TYR | 4.76299 |
[CC] GO:0045121 | membrane raft | APP, BACE1, CNR1, EGFR, HTR2A, INSR, KDR, PTGS2, SRC, TEK | 3.89513 |
[CC] GO:0098857 | membrane microdomain | APP, BACE1, CNR1, EGFR, HTR2A, INSR, KDR, PTGS2, SRC, TEK | 3.87197 |
[CC] GO:0098589 | membrane region | APP, BACE1, CNR1, EGFR, HTR2A, INSR, KDR, PTGS2, SRC, TEK | 3.27395 |
[CC] GO:0044464 | cell part | ABCB1, ACHE, ADORA1, ADORA3, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, APEX1, APP, AURKB, AXL, BACE1, BCL2, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CBR1, CDC25B, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DAO, DNMT1, DUSP3, DYRK1A, EGFR, ESR1, FABP3, FABP4, FLT3, FUCA1, FUT7, GAA, GBA, GLO1, GPR35, HCAR2, HIF1A, HRH3, HRH4, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IDO1, IGF1R, INSR, KDR, MET, MGAM, MMP12, MMP2, MMP9, MPO, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, TOP2A, TYR, XDH | 2.80026 |
[CC] GO:0044444 | cytoplasmic part | ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, APEX1, APP, AURKB, BACE1, BCL2, CA1, CA2, CA4, CA7, CBR1, CDC25B, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DAO, DUSP3, EGFR, ESR1, FABP3, FABP4, FLT3, FUCA1, FUT7, GAA, GBA, GLO1, HIF1A, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, HTR2A, HTR4, HTR5A, IDO1, INSR, KDR, MGAM, MMP2, MMP9, MPO, NQO2, PIK3CA, PIK3CB, PIM1, PTGS1, PTGS2, PTPN1, SMAD3, SRC, TERT, TOP2A, TYR, XDH | 2.33054 |
[CC] GO:0031224 | None | ABCB1, ACHE, ADORA1, ADORA3, ALPL, APP, AXL, BACE1, CA12, CA14, CA4, CA9, CNR1, CNR2, EGFR, ESR1, FLT3, FUT7, GPR35, HCAR2, HRH3, HRH4, HSD11B1, HSD17B2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, MGAM, TEK, TYR | 2.20385 |
[CC] GO:0098590 | plasma membrane region | ABCB1, ADORA1, CA2, CA4, CA9, CNR1, EGFR, HTR2A, INSR, MET, MGAM, PTGS2, SRC, TEK | 2.03249 |
[MF] GO:0099528 | None | HRH3, HRH4, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 | 16.477 |
[MF] GO:0004993 | None | HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 | 15.8578 |
[MF] GO:0099589 | None | HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 | 15.8578 |
[MF] GO:0043176 | None | HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7 | 15.8578 |
[MF] GO:0051378 | None | HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7 | 15.8578 |
[MF] GO:0008227 | None | HRH3, HRH4, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 | 14.8536 |
[MF] GO:0003824 | catalytic activity | ABCB1, ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, APEX1, AURKB, AXL, BACE1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CBR1, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DAO, DNMT1, DUSP3, DYRK1A, EGFR, FLT3, FUCA1, FUT7, GAA, GBA, GLO1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KDR, MET, MGAM, MMP1, MMP12, MMP2, MMP9, MPO, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, PTGS1, PTGS2, PTPN1, SRC, TEK, TERT, TOP2A, TYR, XDH | 12.385 |
[MF] GO:0043167 | ion binding | ABCB1, ACHE, ALOX15, ALOX5, ALPL, APEX1, APP, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DAO, DNMT1, DYRK1A, EGFR, ESR1, FABP3, FABP4, FLT3, GLO1, HSD17B1, HSPA1A, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7, IDO1, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, MPO, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, TOP2A, TYR, XDH | 11.58 |
[MF] GO:0030594 | None | HRH3, HRH4, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 | 11.2207 |
[MF] GO:0042165 | neurotransmitter binding | ACHE, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7 | 10.4024 |
[MF] GO:0004089 | carbonate dehydratase activity | CA1, CA12, CA14, CA2, CA4, CA7, CA9 | 9.70757 |
[MF] GO:0046914 | transition metal ion binding | ALOX15, ALOX5, APP, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, ESR1, GLO1, MMP1, MMP12, MMP2, MMP9, NQO2, PIM1, PPARA, PTPN1, SMAD3, TYR, XDH | 9.48927 |
[MF] GO:0070405 | ammonium ion binding | ACHE, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7 | 8.96899 |
[MF] GO:0016491 | oxidoreductase activity | AKR1B1, AKR1B10, ALOX15, ALOX5, APEX1, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DAO, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IDO1, MPO, NQO2, PTGS1, PTGS2, TYR, XDH | 8.76391 |
[MF] GO:0038023 | signaling receptor activity | ADORA1, ADORA3, AXL, CNR1, CNR2, EGFR, ESR1, FLT3, GPR35, HCAR2, HRH3, HRH4, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, PPARA, TEK | 8.65416 |
[MF] GO:0099600 | transmembrane receptor activity | ADORA1, ADORA3, AXL, CNR1, CNR2, EGFR, FLT3, GPR35, HCAR2, HRH3, HRH4, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, TEK | 8.07424 |
[MF] GO:0004888 | transmembrane signaling receptor activity | ADORA1, ADORA3, AXL, CNR1, CNR2, EGFR, FLT3, GPR35, HCAR2, HRH3, HRH4, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, TEK | 8.07424 |
[MF] GO:0008144 | drug binding | ABCB1, ACHE, AURKB, AXL, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DYRK1A, EGFR, FLT3, HSPA1A, HTR1B, HTR2A, HTR2B, HTR2C, IGF1R, INSR, KDR, MET, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, SRC, TEK, TOP2A | 7.79952 |
[MF] GO:0004872 | receptor activity | ADORA1, ADORA3, AXL, CNR1, CNR2, EGFR, ESR1, FLT3, GPR35, HCAR2, HRH3, HRH4, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, PPARA, TEK | 7.51887 |
[MF] GO:0004871 | signal transducer activity | ADORA1, ADORA3, AXL, CNR1, CNR2, EGFR, ESR1, FLT3, GPR35, HCAR2, HRH3, HRH4, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, PPARA, SMAD3, TEK | 7.24007 |
[MF] GO:0060089 | molecular transducer activity | ADORA1, ADORA3, AXL, CNR1, CNR2, EGFR, ESR1, FLT3, GPR35, HCAR2, HRH3, HRH4, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, PPARA, TEK | 7.22903 |
[MF] GO:0043169 | cation binding | ACHE, ALOX15, ALOX5, ALPL, APEX1, APP, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, ESR1, GLO1, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7, IDO1, MMP1, MMP12, MMP2, MMP9, MPO, NQO2, NUAK1, PIM1, PPARA, PTGS1, PTGS2, PTPN1, SMAD3, TERT, TOP2A, TYR, XDH | 6.99071 |
[MF] GO:0004714 | transmembrane receptor protein tyrosine kinase activity | AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, TEK | 6.812 |
[MF] GO:0016835 | carbon-oxygen lyase activity | APEX1, CA1, CA12, CA14, CA2, CA4, CA7, CA9 | 6.21346 |
[MF] GO:0019199 | transmembrane receptor protein kinase activity | AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, TEK | 6.05644 |
[MF] GO:0016836 | hydro-lyase activity | CA1, CA12, CA14, CA2, CA4, CA7, CA9 | 5.83725 |
[MF] GO:0020037 | heme binding | CYP19A1, CYP1A1, CYP1A2, CYP1B1, IDO1, MPO, PTGS1, PTGS2, SRC | 5.72487 |
[MF] GO:0004713 | protein tyrosine kinase activity | AXL, DYRK1A, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK | 5.56744 |
[MF] GO:0046906 | tetrapyrrole binding | CYP19A1, CYP1A1, CYP1A2, CYP1B1, IDO1, MPO, PTGS1, PTGS2, SRC | 5.48264 |
[MF] GO:0004930 | None | ADORA1, ADORA3, CNR1, CNR2, GPR35, HCAR2, HRH3, HRH4, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 | 5.40542 |
[MF] GO:0048037 | cofactor binding | CYP19A1, CYP1A1, CYP1A2, CYP1B1, DAO, HSD11B2, HSD17B1, IDO1, MPO, NQO2, PTGS1, PTGS2, SRC, XDH | 5.01704 |
[MF] GO:0043560 | insulin receptor substrate binding | IGF1R, INSR, PIK3CA, PIK3CB | 4.72225 |
[MF] GO:0016829 | lyase activity | APEX1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, GLO1 | 4.5337 |
[MF] GO:0008270 | zinc ion binding | CA1, CA12, CA2, CA4, CA7, CA9, DNMT1, ESR1, GLO1, MMP1, MMP12, MMP2, MMP9, NQO2, PPARA, PTPN1, SMAD3 | 4.4769 |
[MF] GO:0016614 | oxidoreductase activity, acting on CH-OH group of donors | AKR1B1, AKR1B10, CBR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, XDH | 4.46932 |
[MF] GO:1901363 | heterocyclic compound binding | ABCB1, ADORA1, APEX1, APP, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DAO, DNMT1, DYRK1A, EGFR, ESR1, FLT3, HIF1A, HSD11B2, HSD17B1, HSPA1A, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7, IDO1, IGF1R, INSR, KDR, MET, MMP12, MPO, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, TOP2A, XDH | 4.34528 |
[MF] GO:0004672 | protein kinase activity | AURKB, AXL, CSNK2A1, DYRK1A, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIM1, SRC, TEK | 4.27468 |
[MF] GO:0097159 | organic cyclic compound binding | ABCB1, ADORA1, APEX1, APP, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DAO, DNMT1, DYRK1A, EGFR, ESR1, FLT3, HIF1A, HSD11B2, HSD17B1, HSPA1A, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7, IDO1, IGF1R, INSR, KDR, MET, MMP12, MPO, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, TOP2A, XDH | 4.2632 |
[MF] GO:0016773 | phosphotransferase activity, alcohol group as acceptor | AURKB, AXL, CSNK2A1, DYRK1A, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIK3CB, PIM1, SRC, TEK | 4.04285 |
[MF] GO:0016616 | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | AKR1B1, AKR1B10, CBR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 | 3.84043 |
[MF] GO:0004969 | None | HRH3, HRH4, HTR6 | 3.75519 |
[MF] GO:0016301 | kinase activity | AURKB, AXL, CSNK2A1, DYRK1A, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIK3CB, PIM1, SRC, TEK | 3.61493 |
[MF] GO:0042562 | hormone binding | ACHE, EGFR, HSD17B1, IGF1R, INSR, NQO2 | 3.58587 |
[MF] GO:0070330 | aromatase activity | CYP19A1, CYP1A1, CYP1A2, CYP1B1 | 3.51163 |
[MF] GO:0044877 | macromolecular complex binding | ACHE, ADORA1, APEX1, CSNK2A1, EGFR, FLT3, HTR2A, IGF1R, INSR, KDR, MMP12, MMP9, PIM1, PPARA, PTPN1, SMAD3, SRC | 3.49125 |
[MF] GO:0032403 | protein complex binding | ACHE, ADORA1, APEX1, EGFR, FLT3, HTR2A, IGF1R, INSR, KDR, MMP12, MMP9, PPARA, PTPN1, SMAD3, SRC | 3.397 |
[MF] GO:0016772 | transferase activity, transferring phosphorus-containing groups | AURKB, AXL, CSNK2A1, DYRK1A, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIK3CB, PIM1, SRC, TEK, TERT | 3.36991 |
[MF] GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen | CYP19A1, CYP1A1, CYP1A2, CYP1B1 | 3.31894 |
[MF] GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen | ALOX15, ALOX5, IDO1, PTGS2 | 3.31894 |
[MF] GO:0033764 | steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | HSD11B1, HSD11B2, HSD17B1, HSD17B2 | 3.26448 |
[MF] GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen | ALOX15, ALOX5, IDO1, PTGS2 | 3.26448 |
[MF] GO:0004716 | signal transducer, downstream of receptor, with protein tyrosine kinase activity | EGFR, INSR, KDR | 3.23308 |
[MF] GO:0016705 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | CYP19A1, CYP1A1, CYP1A2, CYP1B1, PTGS1, PTGS2, TYR | 3.1921 |
[MF] GO:0036094 | small molecule binding | ABCB1, ADORA1, AURKB, AXL, CSNK2A1, DAO, DNMT1, DYRK1A, EGFR, FABP3, FABP4, FLT3, HSD11B2, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, SRC, TEK, TOP2A, XDH | 3.18886 |
[MF] GO:0016229 | steroid dehydrogenase activity | HSD11B1, HSD11B2, HSD17B1, HSD17B2 | 3.15587 |
[MF] GO:0005506 | iron ion binding | ALOX15, ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, XDH | 3.11359 |
[MF] GO:0000166 | nucleotide binding | ABCB1, AURKB, AXL, CSNK2A1, DAO, DNMT1, DYRK1A, EGFR, FLT3, HSD11B2, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, SRC, TEK, TOP2A, XDH | 3.07733 |
[MF] GO:1901265 | nucleoside phosphate binding | ABCB1, AURKB, AXL, CSNK2A1, DAO, DNMT1, DYRK1A, EGFR, FLT3, HSD11B2, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, SRC, TEK, TOP2A, XDH | 3.07724 |
[MF] GO:0009055 | electron transfer activity | AKR1B1, CYP19A1, CYP1A2, IDO1, NQO2, XDH | 3.07724 |
[MF] GO:0046872 | metal ion binding | ALOX15, ALOX5, ALPL, APEX1, APP, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, ESR1, GLO1, IDO1, MMP1, MMP12, MMP2, MMP9, MPO, NQO2, NUAK1, PIM1, PPARA, PTGS1, PTGS2, PTPN1, SMAD3, TERT, TOP2A, TYR, XDH | 2.94256 |
[MF] GO:0004666 | prostaglandin-endoperoxide synthase activity | PTGS1, PTGS2 | 2.88251 |
[MF] GO:0003845 | None | HSD11B1, HSD11B2 | 2.88251 |
[MF] GO:0071886 | None | HTR2A, HTR2C | 2.88251 |
[MF] GO:0019825 | oxygen binding | CYP19A1, CYP1A1, CYP1A2, CYP1B1 | 2.49985 |
[MF] GO:0043168 | anion binding | ABCB1, ALOX15, APP, AURKB, AXL, CSNK2A1, DAO, DYRK1A, EGFR, FABP3, FABP4, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, MPO, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, SRC, TEK, TOP2A, XDH | 2.49524 |
[MF] GO:0005524 | ATP binding | ABCB1, AURKB, AXL, CSNK2A1, DYRK1A, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIK3CB, PIM1, SRC, TEK, TOP2A | 2.4908 |
[MF] GO:0050473 | arachidonate 15-lipoxygenase activity | ALOX15, PTGS2 | 2.48 |
[MF] GO:0004949 | None | CNR1, CNR2 | 2.48 |
[MF] GO:0032450 | None | GAA, MGAM | 2.48 |
[MF] GO:0051213 | dioxygenase activity | ALOX15, ALOX5, IDO1, PTGS1, PTGS2 | 2.45061 |
[MF] GO:0003674 | molecular_function | ABCB1, ACHE, ADORA1, ADORA3, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, APEX1, APP, AURKB, AXL, BACE1, BCL2, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CBR1, CDC25B, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DAO, DNMT1, DUSP3, DYRK1A, EGFR, ESR1, FABP3, FABP4, FLT3, FUCA1, FUT7, GAA, GBA, GLO1, GPR35, HCAR2, HIF1A, HRH3, HRH4, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IDO1, IGF1R, INSR, KDR, MET, MGAM, MMP1, MMP12, MMP2, MMP9, MPO, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, TOP2A, TYR, XDH | 2.39686 |
[MF] GO:0032559 | adenyl ribonucleotide binding | ABCB1, AURKB, AXL, CSNK2A1, DYRK1A, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIK3CB, PIM1, SRC, TEK, TOP2A | 2.38052 |
[MF] GO:0004497 | monooxygenase activity | CYP19A1, CYP1A1, CYP1A2, CYP1B1, TYR | 2.36117 |
[MF] GO:0030554 | adenyl nucleotide binding | ABCB1, AURKB, AXL, CSNK2A1, DYRK1A, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIK3CB, PIM1, SRC, TEK, TOP2A | 2.35033 |
[MF] GO:0001223 | transcription coactivator binding | ESR1, PPARA, TERT | 2.29057 |
[MF] GO:0051425 | None | APP, INSR | 2.24217 |
[MF] GO:0004558 | None | GAA, MGAM | 2.24217 |
[MF] GO:0019902 | phosphatase binding | BCL2, EGFR, MET, PPARA, PTPN1, SMAD3 | 2.23024 |
[MF] GO:0031072 | heat shock protein binding | ADORA1, CSNK2A1, HIF1A, HSPA1A, KDR | 2.20143 |
[MF] GO:0043559 | insulin binding | IGF1R, INSR | 2.05696 |
[MF] GO:0042802 | identical protein binding | ACHE, APP, BCL2, CSNK2A1, DYRK1A, EGFR, ESR1, FLT3, IGF1R, KDR, MET, MMP9, NQO2, PTGS2, SMAD3, TERT, TOP2A, TYR, XDH | 2.03293 |
[MF] GO:0005518 | collagen binding | ACHE, MMP12, MMP9, SMAD3 | 2.03293 |
KEGG Pathway ID | Enriched Genes | Log10 Adjusted P-value |
---|---|---|
Serotonergic synapse_Homo sapiens_hsa04726 | APP, HTR1E, ALOX15, HTR1D, HTR2B, HTR1A, HTR1B, HTR2C, HTR2A, PTGS2, HTR5A, HTR4, PTGS1, HTR6, HTR7, ALOX5 | 16.8658 |
Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | HTR1E, GPR35, HTR1D, HTR2B, HTR1A, HTR1B, HTR2C, HTR2A, HTR5A, HTR4, HTR6, HTR7, HRH3, CNR2, CNR1, ADORA3, HRH4, ADORA1 | 13.317 |
Ovarian steroidogenesis_Homo sapiens_hsa04913 | ALOX5, INSR, HSD17B1, HSD17B2, CYP1A1, CYP1B1, PTGS2, CYP19A1, IGF1R | 10.2162 |
Nitrogen metabolism_Homo sapiens_hsa00910 | CA12, CA1, CA2, CA4, CA7, CA9, CA14 | 10.4123 |
Proteoglycans in cancer_Homo sapiens_hsa05205 | PIK3CA, SRC, MMP2, KDR, PIK3CB, MMP9, MET, ESR1, HIF1A, EGFR, IGF1R | 7.26 |
Steroid hormone biosynthesis_Homo sapiens_hsa00140 | HSD11B1, HSD11B2, HSD17B1, HSD17B2, CYP1A2, CYP1A1, CYP1B1, CYP19A1 | 8.0727 |
cAMP signaling pathway_Homo sapiens_hsa04024 | HCAR2, HTR6, PIK3CA, HTR1E, HTR1D, ADORA1, HTR1A, HTR1B, PIK3CB, PPARA, HTR4 | 7.293 |
Adherens junction_Homo sapiens_hsa04520 | PTPN1, SMAD3, CSNK2A1, SRC, INSR, MET, EGFR, IGF1R | 7.293 |
Metabolic pathways_Homo sapiens_hsa01100 | CBR1, MGAM, DNMT1, GAA, ALOX15, GBA, AKR1B1, PTGS2, TYR, CYP19A1, PTGS1, HSD11B1, FUT7, DAO, AKR1B10, ALOX5, HSD17B1, HSD17B2, CYP1A2, CYP1A1, ALPL, XDH, IDO1 | 6.8969 |
Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | FABP4, PIK3CA, INSR, ADORA1, PIK3CB, PTGS2, PTGS1 | 6.8969 |
Pathways in cancer_Homo sapiens_hsa05200 | SMAD3, FLT3, MMP1, MMP2, PIK3CB, PTGS2, MMP9, HIF1A, EGFR, IGF1R, PIK3CA, BCL2, MET | 6.3174 |
Estrogen signaling pathway_Homo sapiens_hsa04915 | PIK3CA, SRC, MMP2, PIK3CB, MMP9, ESR1, EGFR, HSPA1A | 6.5317 |
Rap1 signaling pathway_Homo sapiens_hsa04015 | PIK3CA, SRC, CNR1, INSR, KDR, TEK, PIK3CB, MET, EGFR, IGF1R | 6.2097 |
HIF-1 signaling pathway_Homo sapiens_hsa04066 | PIK3CA, INSR, BCL2, TEK, PIK3CB, HIF1A, EGFR, IGF1R | 6.4333 |
MicroRNAs in cancer_Homo sapiens_hsa05206 | DNMT1, ABCB1, PIK3CA, BCL2, PIM1, CYP1B1, PTGS2, MMP9, MET, EGFR, CDC25B | 5.8312 |
Ras signaling pathway_Homo sapiens_hsa04014 | HTR7, PIK3CA, INSR, KDR, TEK, PIK3CB, MET, EGFR, IGF1R | 4.9602 |
Calcium signaling pathway_Homo sapiens_hsa04020 | HTR6, HTR7, HTR2B, HTR2C, HTR2A, HTR5A, HTR4, EGFR | 4.7675 |
Central carbon metabolism in cancer_Homo sapiens_hsa05230 | PIK3CA, FLT3, PIK3CB, MET, HIF1A, EGFR | 5.1502 |
Focal adhesion_Homo sapiens_hsa04510 | PIK3CA, SRC, KDR, BCL2, PIK3CB, MET, EGFR, IGF1R | 4.4388 |
AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | SMAD3, PIK3CA, MMP2, BCL2, PIM1, PIK3CB | 4.2591 |
Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | PIK3CA, SRC, HTR2B, HTR2C, PIK3CB, HTR2A | 4.3155 |
Chemical carcinogenesis_Homo sapiens_hsa05204 | HSD11B1, CBR1, CYP1A2, CYP1A1, CYP1B1, PTGS2 | 4.7263 |
Bladder cancer_Homo sapiens_hsa05219 | SRC, MMP1, MMP2, MMP9, EGFR | 4.9278 |
PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | PIK3CA, INSR, KDR, BCL2, TEK, PIK3CB, MET, EGFR, IGF1R | 3.7804 |
VEGF signaling pathway_Homo sapiens_hsa04370 | PIK3CA, SRC, KDR, PIK3CB, PTGS2 | 4.1848 |
Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | PIK3CA, INSR, PIK3CB, IGF1R, HSPA1A | 4.133 |
Arachidonic acid metabolism_Homo sapiens_hsa00590 | CBR1, ALOX5, ALOX15, PTGS2, PTGS1 | 4.1676 |
Melanoma_Homo sapiens_hsa05218 | PIK3CA, PIK3CB, MET, EGFR, IGF1R | 3.9274 |
FoxO signaling pathway_Homo sapiens_hsa04068 | SMAD3, PIK3CA, INSR, PIK3CB, EGFR, IGF1R | 3.7342 |
Hepatitis B_Homo sapiens_hsa05161 | SMAD3, PIK3CA, SRC, BCL2, PIK3CB, MMP9 | 3.5456 |
Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | HSD11B1, CBR1, CYP1A2, CYP1A1, CYP1B1 | 3.8837 |
Prostate cancer_Homo sapiens_hsa05215 | PIK3CA, BCL2, PIK3CB, EGFR, IGF1R | 3.5494 |
Endocytosis_Homo sapiens_hsa04144 | SMAD3, SRC, KDR, MET, EGFR, IGF1R, HSPA1A | 3.0664 |
Gap junction_Homo sapiens_hsa04540 | SRC, HTR2B, HTR2C, HTR2A, EGFR | 3.5605 |
Insulin resistance_Homo sapiens_hsa04931 | PTPN1, PIK3CA, INSR, PIK3CB, PPARA | 3.1675 |
Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | PIK3CA, SRC, PIK3CB, ESR1, HIF1A | 3.06 |
Toxoplasmosis_Homo sapiens_hsa05145 | PIK3CA, ALOX5, BCL2, PIK3CB, HSPA1A | 3.06 |
Sphingolipid signaling pathway_Homo sapiens_hsa04071 | PIK3CA, ADORA3, BCL2, ADORA1, PIK3CB | 3.0484 |
Acute myeloid leukemia_Homo sapiens_hsa05221 | PIK3CA, FLT3, PIM1, PIK3CB | 3.1918 |
Colorectal cancer_Homo sapiens_hsa05210 | SMAD3, PIK3CA, BCL2, PIK3CB | 3.0724 |
Oxytocin signaling pathway_Homo sapiens_hsa04921 | PIK3CA, SRC, PIK3CB, PTGS2, EGFR | 2.5789 |
Glioma_Homo sapiens_hsa05214 | PIK3CA, PIK3CB, EGFR, IGF1R | 3.0484 |
cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | PIK3CA, ADORA3, INSR, ADORA1, PIK3CB | 2.487 |
Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | HSD11B2, PIK3CA, INSR, PIK3CB | 3.7688 |
Taste transduction_Homo sapiens_hsa04742 | HTR1E, HTR1D, HTR1A, HTR1B | 2.7036 |
Pancreatic cancer_Homo sapiens_hsa05212 | SMAD3, PIK3CA, PIK3CB, EGFR | 3.0484 |
Prolactin signaling pathway_Homo sapiens_hsa04917 | PIK3CA, SRC, PIK3CB, ESR1 | 2.9212 |
ErbB signaling pathway_Homo sapiens_hsa04012 | PIK3CA, SRC, PIK3CB, EGFR | 2.643 |
Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | PIK3CA, PIK3CB, CDC25B, IGF1R | 2.4812 |
Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | PIK3CA, INSR, PIK3CB, IGF1R | 2.5331 |
Renal cell carcinoma_Homo sapiens_hsa05211 | PIK3CA, PIK3CB, MET, HIF1A | 3.0484 |
Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | FLT3, MMP9, MET, MPO, IGF1R | 2.38 |
Tryptophan metabolism_Homo sapiens_hsa00380 | CYP1A2, CYP1A1, CYP1B1, IDO1 | 3.7383 |
Small cell lung cancer_Homo sapiens_hsa05222 | PIK3CA, BCL2, PIK3CB, PTGS2 | 2.6536 |
Galactose metabolism_Homo sapiens_hsa00052 | MGAM, AKR1B10, GAA, AKR1B1 | 4.1557 |
Choline metabolism in cancer_Homo sapiens_hsa05231 | PIK3CA, PIK3CB, HIF1A, EGFR | 2.4477 |
Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | PIK3CA, SRC, PIK3CB, MET | 2.7972 |
Cholinergic synapse_Homo sapiens_hsa04725 | ACHE, PIK3CA, BCL2, PIK3CB | 2.325 |
Epstein-Barr virus infection_Homo sapiens_hsa05169 | CSNK2A1, PIK3CA, BCL2, PIK3CB, HSPA1A | 2.2087 |
TNF signaling pathway_Homo sapiens_hsa04668 | PIK3CA, PIK3CB, PTGS2, MMP9 | 2.3325 |
Platelet activation_Homo sapiens_hsa04611 | PIK3CA, SRC, PIK3CB, PTGS1 | 2.2087 |
PPAR signaling pathway_Homo sapiens_hsa03320 | FABP3, FABP4, MMP1, PPARA | 2.983 |
Leukocyte transendothelial migration_Homo sapiens_hsa04670 | PIK3CA, MMP2, PIK3CB, MMP9 | 2.2458 |
AMPK signaling pathway_Homo sapiens_hsa04152 | PIK3CA, INSR, PIK3CB, IGF1R | 2.1896 |
Measles_Homo sapiens_hsa05162 | CSNK2A1, PIK3CA, PIK3CB, HSPA1A | 2.07 |
Hepatitis C_Homo sapiens_hsa05160 | PIK3CA, PIK3CB, PPARA, EGFR | 2.0986 |
Phospholipase D signaling pathway_Homo sapiens_hsa04072 | PIK3CA, INSR, PIK3CB, EGFR | 2.005 |
Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | SMAD3, PIK3CA, PIK3CB, IGF1R | 2.0208 |
Insulin signaling pathway_Homo sapiens_hsa04910 | PTPN1, PIK3CA, INSR, PIK3CB | 2.048 |
Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | PIK3CA, INSR, PIK3CB, PPARA | 1.9488 |
Jak-STAT signaling pathway_Homo sapiens_hsa04630 | PIK3CA, BCL2, PIM1, PIK3CB | 1.8854 |
Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | PIK3CA, SRC, PIK3CB, EGFR | 1.475 |
Herpes simplex infection_Homo sapiens_hsa05168 | CSNK2A1 | 0.2369 |
Purine metabolism_Homo sapiens_hsa00230 | XDH | 0.2482 |
Apoptosis_Homo sapiens_hsa04210 | PIK3CA, BCL2, PIK3CB | 1.2983 |
MAPK signaling pathway_Homo sapiens_hsa04010 | DUSP3, EGFR, CDC25B, HSPA1A | 1.2588 |
Hippo signaling pathway_Homo sapiens_hsa04390 | SMAD3 | 0.2842 |
Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | FLT3, KDR, MET, EGFR | 1.2202 |
Phagosome_Homo sapiens_hsa04145 | MPO | 0.2842 |
HTLV-I infection_Homo sapiens_hsa05166 | SMAD3, PIK3CA, TERT, PIK3CB | 1.252 |
Spliceosome_Homo sapiens_hsa03040 | HSPA1A | 0.3214 |
Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | PIK3CA, BCL2, PIK3CB | 1.2555 |
Neurotrophin signaling pathway_Homo sapiens_hsa04722 | PIK3CA, BCL2, PIK3CB | 1.4624 |
Lysosome_Homo sapiens_hsa04142 | FUCA1, GAA, GBA | 1.4391 |
Axon guidance_Homo sapiens_hsa04360 | MET | 0.3356 |
Oocyte meiosis_Homo sapiens_hsa04114 | IGF1R | 0.3432 |
Viral carcinogenesis_Homo sapiens_hsa05203 | PIK3CA, SRC, PIK3CB | 0.969 |
Influenza A_Homo sapiens_hsa05164 | PIK3CA, PIK3CB, HSPA1A | 1.1092 |
Chemokine signaling pathway_Homo sapiens_hsa04062 | PIK3CA, SRC, PIK3CB | 1.0444 |
Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | SMAD3, PIK3CA, PIK3CB | 1.6176 |
Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | BCL2, HSPA1A | 0.6319 |
GnRH signaling pathway_Homo sapiens_hsa04912 | SRC, MMP2, EGFR | 1.7542 |
Alzheimer's disease_Homo sapiens_hsa05010 | BACE1, APP | 0.6319 |
Tight junction_Homo sapiens_hsa04530 | CSNK2A1, SRC | 0.7305 |
Wnt signaling pathway_Homo sapiens_hsa04310 | SMAD3, CSNK2A1 | 0.7192 |
Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | PIK3CA, PIK3CB | 0.7438 |
Tuberculosis_Homo sapiens_hsa05152 | SRC, BCL2 | 0.6139 |
Glucagon signaling pathway_Homo sapiens_hsa04922 | PPARA | 0.4058 |
Melanogenesis_Homo sapiens_hsa04916 | TYR | 0.4065 |
Osteoclast differentiation_Homo sapiens_hsa04380 | PIK3CA, PIK3CB | 0.756 |
Cell cycle_Homo sapiens_hsa04110 | SMAD3, CDC25B | 0.7867 |
Glycerophospholipid metabolism_Homo sapiens_hsa00564 | ACHE | 0.4186 |
Pancreatic secretion_Homo sapiens_hsa04972 | CA2 | 0.4178 |
Morphine addiction_Homo sapiens_hsa05032 | ADORA1 | 0.4307 |
NF-kappa B signaling pathway_Homo sapiens_hsa04064 | CSNK2A1, BCL2, PTGS2 | 1.7338 |
Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | PIK3CA, PIK3CB | 0.8959 |
Hematopoietic cell lineage_Homo sapiens_hsa04640 | FLT3 | 0.4369 |
GABAergic synapse_Homo sapiens_hsa04727 | SRC | 0.4369 |
TGF-beta signaling pathway_Homo sapiens_hsa04350 | SMAD3 | 0.4476 |
T cell receptor signaling pathway_Homo sapiens_hsa04660 | PIK3CA, PIK3CB | 0.9062 |
Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | CSNK2A1 | 0.4358 |
Amoebiasis_Homo sapiens_hsa05146 | PIK3CA, PIK3CB | 0.9274 |
Chronic myeloid leukemia_Homo sapiens_hsa05220 | SMAD3, PIK3CA, PIK3CB | 1.9923 |
Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | PIK3CA, PIK3CB | 0.9702 |
Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | CNR1, PTGS2 | 0.9241 |
Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | PIK3CA, PIK3CB | 0.9385 |
Rheumatoid arthritis_Homo sapiens_hsa05323 | MMP1, TEK | 0.991 |
Antigen processing and presentation_Homo sapiens_hsa04612 | HSPA1A | 0.476 |
Leishmaniasis_Homo sapiens_hsa05140 | PTGS2 | 0.4895 |
Gastric acid secretion_Homo sapiens_hsa04971 | CA2 | 0.4874 |
mTOR signaling pathway_Homo sapiens_hsa04150 | PIK3CA, PIK3CB, HIF1A | 2.1857 |
Adipocytokine signaling pathway_Homo sapiens_hsa04920 | PPARA | 0.502 |
Non-small cell lung cancer_Homo sapiens_hsa05223 | PIK3CA, PIK3CB, EGFR | 2.2458 |
Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | SRC, MET, EGFR | 2.0557 |
Peroxisome_Homo sapiens_hsa04146 | DAO, XDH | 1.0444 |
Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | CYP1A2 | 0.5043 |
B cell receptor signaling pathway_Homo sapiens_hsa04662 | PIK3CA, PIK3CB | 1.1312 |
Endometrial cancer_Homo sapiens_hsa05213 | PIK3CA, PIK3CB, EGFR | 2.325 |
Renin secretion_Homo sapiens_hsa04924 | ADORA1 | 0.5235 |
Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | PIK3CA, PIK3CB | 1.1739 |
Shigellosis_Homo sapiens_hsa05131 | SRC | 0.5235 |
Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | SMAD3 | 0.5235 |
Inositol phosphate metabolism_Homo sapiens_hsa00562 | PIK3CA, PIK3CB | 1.1486 |
Long-term depression_Homo sapiens_hsa04730 | IGF1R | 0.5444 |
Bile secretion_Homo sapiens_hsa04976 | ABCB1, CA2 | 1.1486 |
Type II diabetes mellitus_Homo sapiens_hsa04930 | PIK3CA, INSR, PIK3CB | 2.3976 |
Retinol metabolism_Homo sapiens_hsa00830 | CYP1A2, CYP1A1 | 1.205 |
Legionellosis_Homo sapiens_hsa05134 | HSPA1A | 0.5743 |
Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | MGAM, PIK3CA, PIK3CB | 2.4645 |
Glycerolipid metabolism_Homo sapiens_hsa00561 | AKR1B10, AKR1B1 | 1.2594 |
Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | BCL2 | 0.6002 |
Arginine and proline metabolism_Homo sapiens_hsa00330 | DAO | 0.6047 |
Malaria_Homo sapiens_hsa05144 | MET | 0.6092 |
Starch and sucrose metabolism_Homo sapiens_hsa00500 | MGAM, GAA | 1.2965 |
Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | ESR1 | 0.6191 |
Drug metabolism - other enzymes_Homo sapiens_hsa00983 | XDH | 0.6211 |
Sphingolipid metabolism_Homo sapiens_hsa00600 | GBA | 0.6191 |
ABC transporters_Homo sapiens_hsa02010 | ABCB1 | 0.6319 |
Cysteine and methionine metabolism_Homo sapiens_hsa00270 | DNMT1 | 0.6264 |
Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | DAO | 0.6594 |
Prion diseases_Homo sapiens_hsa05020 | HSPA1A | 0.7058 |
Pyruvate metabolism_Homo sapiens_hsa00620 | GLO1 | 0.6594 |
African trypanosomiasis_Homo sapiens_hsa05143 | IDO1 | 0.7058 |
Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | FUT7 | 0.7335 |
Dorso-ventral axis formation_Homo sapiens_hsa04320 | EGFR | 0.7788 |
Tyrosine metabolism_Homo sapiens_hsa00350 | TYR | 0.7058 |
Base excision repair_Homo sapiens_hsa03410 | APEX1 | 0.719 |
Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | FUT7 | 0.7867 |
Collecting duct acid secretion_Homo sapiens_hsa04966 | CA2 | 0.7788 |
Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | AKR1B10, AKR1B1 | 1.6295 |
Fructose and mannose metabolism_Homo sapiens_hsa00051 | AKR1B10, AKR1B1 | 1.7231 |
Linoleic acid metabolism_Homo sapiens_hsa00591 | ALOX15, CYP1A2 | 1.7905 |
Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | CA2, CA4 | 1.9718 |
Folate biosynthesis_Homo sapiens_hsa00790 | ALPL | 1.0045 |
Other glycan degradation_Homo sapiens_hsa00511 | FUCA1, GBA | 2.1373 |
Caffeine metabolism_Homo sapiens_hsa00232 | CYP1A2, XDH | 3.0664 |